{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":189,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":189,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"dedd6f837dfb","filters":{"venue":"Hematological Oncology"}},"results":[{"id":"W2130207527","doi":"10.1002/hon.802","title":"Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy","year":2006,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Connaught Fund","keywords":"ABVD; Medicine; Pregnancy; Dacarbazine; Fertility; Vinblastine; Pregnancy rate; Chemotherapy regimen; Chemotherapy; Obstetrics; Gynecology; Pediatrics; Surgery; Cyclophosphamide; Population; Vincristine","authors":[{"name":"David Hodgson","is_ca":true},{"name":"Melania Pintilie","is_ca":true},{"name":"Leah Gitterman","is_ca":true},{"name":"Beth DeWitt","is_ca":true},{"name":"C Buckley","is_ca":true},{"name":"Sameera Ahmed","is_ca":true},{"name":"Katherine Smith","is_ca":true},{"name":"A. K. Schwartz","is_ca":true},{"name":"Richard Tsang","is_ca":true},{"name":"Michael Crump","is_ca":true},{"name":"Woodrow Wells","is_ca":true},{"name":"A. Sun","is_ca":true},{"name":"Mary Gospodarowicz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03023768325960741,"gpt":0.3238924048666322,"spread":0.2936547216070248,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003143729,0.0002969165,0.001043902,0.00008140338,0.000154947,0.00002739637,0.0001525,0.0005039168,0.0003306914],"category_scores_gemma":[0.0001322639,0.0002246178,0.0004020815,0.0002701279,0.0002250189,0.0001161415,0.00007180325,0.0002399193,0.00004965713],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000331058,"about_ca_system_score_gemma":0.0001362794,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001600941,"about_ca_topic_score_gemma":0.0009463233,"domain_scores_codex":[0.9976845,0.0001450673,0.0006448464,0.0006122491,0.0002770871,0.0006361838],"domain_scores_gemma":[0.9988531,0.0003210085,0.0002121226,0.0003780438,0.00005846059,0.0001772303],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002031441,0.0007396612,0.978043,0.00008170443,0.00005942053,0.0007641846,0.0001494584,0.000002457907,0.0007593892,0.0004241274,0.0002770857,0.01849634],"study_design_scores_gemma":[0.003189965,0.0006313334,0.9869158,0.0001891588,0.00007056522,0.0001036694,0.0001755246,0.00007811812,0.0019251,0.0005170996,0.005940799,0.0002628403],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9841135,0.0009823352,0.0004750248,0.0006817647,0.0004001428,0.0005695923,0.000003702531,0.0002553187,0.01251862],"genre_scores_gemma":[0.9972662,0.00002748714,0.001150834,0.0004843902,0.0001098277,0.00008451578,0.00002304009,0.00003269321,0.0008210526],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0182335,"threshold_uncertainty_score":0.915965,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2951720456","doi":"10.1002/hon.5_2629","title":"ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R<sup>2</sup>‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Lenalidomide; Medicine; Diffuse large B-cell lymphoma; CHOP; Internal medicine; Rituximab; Clinical endpoint; Placebo; Gastroenterology; Lymphoma; Vincristine; Oncology; Pathology; Randomized controlled trial; Chemotherapy; Cyclophosphamide; Multiple myeloma","authors":[{"name":"Umberto Vitolo","is_ca":false},{"name":"Thomas E. Witzig","is_ca":false},{"name":"Randy D. Gascoyne","is_ca":true},{"name":"David W. Scott","is_ca":true},{"name":"Q. Zhang","is_ca":false},{"name":"Wojciech Jurczak","is_ca":false},{"name":"Muhıt Özcan","is_ca":false},{"name":"Xin Hong","is_ca":false},{"name":"Jun Zhu","is_ca":false},{"name":"Jie Jin","is_ca":false},{"name":"David Belada","is_ca":false},{"name":"Juan Bergua","is_ca":false},{"name":"Francesco Piazza","is_ca":false},{"name":"Heidi Móciková","is_ca":false},{"name":"Anna Lia Molinari","is_ca":false},{"name":"Dok Hyun Yoon","is_ca":false},{"name":"Federica Cavallo","is_ca":false},{"name":"Monica Tani","is_ca":false},{"name":"Koji Izutsu","is_ca":false},{"name":"Koji Kato","is_ca":false},{"name":"M. S. Czuczman","is_ca":false},{"name":"S. J. Hersey","is_ca":false},{"name":"Adrian Kilcoyne","is_ca":false},{"name":"Jacqueline Russo","is_ca":false},{"name":"Krista Hudak","is_ca":false},{"name":"J. Zhang","is_ca":false},{"name":"Annalisa Chiappella","is_ca":false},{"name":"Grzegorz S. Nowakowski","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02707653928937821,"gpt":0.3086064026914633,"spread":0.2815298634020851,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001669205,0.0006421448,0.005580916,0.0003748054,0.00008317459,0.00001364647,0.000314256,0.0007128677,0.001139609],"category_scores_gemma":[0.001459206,0.0004282425,0.0005675643,0.0006901387,0.0002791995,0.00009803857,0.0002504541,0.0002763182,0.0001336097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005764586,"about_ca_system_score_gemma":0.0005019684,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006112547,"about_ca_topic_score_gemma":0.0002294543,"domain_scores_codex":[0.9936457,0.0009912757,0.002835555,0.001076938,0.0005930879,0.0008574745],"domain_scores_gemma":[0.9936407,0.00322138,0.001323366,0.001084586,0.0003653971,0.0003646097],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4576057,0.2160935,0.2947221,0.0008437205,0.001503464,0.02037758,0.004807062,0.0003922936,0.0002887388,0.0006269808,0.00208179,0.0006571189],"study_design_scores_gemma":[0.9701864,0.01197037,0.00575558,0.0003708532,0.001332675,0.002198941,0.001625575,0.00264818,0.001349704,0.00006771865,0.002074273,0.0004197601],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872286,0.00107,0.00001692113,0.0005330084,0.0002002862,0.00705826,0.0000176766,0.0001054392,0.003769796],"genre_scores_gemma":[0.997218,0.0006232635,0.0004166573,0.0002656262,0.00004625481,0.0006633927,0.00008769361,0.00004947622,0.0006297039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5125807,"threshold_uncertainty_score":0.999817,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2968968970","doi":"10.1002/hon.2666","title":"Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis","year":2019,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Impact","funders":"Cancer Research UK; European Hematology Association","keywords":"Rituximab; Medicine; Primary central nervous system lymphoma; Internal medicine; Oncology; Lymphoma; Randomized controlled trial; Clinical trial; Meta-analysis; Diffuse large B-cell lymphoma","authors":[{"name":"Andreas M. Schmitt","is_ca":false},{"name":"Amanda K. Herbrand","is_ca":false},{"name":"Christopher P. Fox","is_ca":false},{"name":"Katerina Bakunina","is_ca":false},{"name":"Jacoline E. C. Bromberg","is_ca":false},{"name":"Kate Cwynarski","is_ca":false},{"name":"Jeanette K. Doorduijn","is_ca":false},{"name":"Andrés J.M. Ferreri","is_ca":false},{"name":"Gerald Illerhaus","is_ca":false},{"name":"Samar Issa","is_ca":false},{"name":"Elisabeth Schorb","is_ca":false},{"name":"Emanuele Zucca","is_ca":false},{"name":"Lars G. Hemkens","is_ca":false},{"name":"Stefan Schandelmaier","is_ca":true},{"name":"Benjamin Kasenda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09136588791526158,"gpt":0.368136584382143,"spread":0.2767706964668814,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0007106985,0.0009174029,0.03569552,0.0004950864,0.00004986781,0.00002610802,0.0002657025,0.001056553,0.0002035304],"category_scores_gemma":[0.0001851068,0.0004975096,0.00397545,0.001060748,0.0001293748,0.00004017174,0.0002344349,0.0003124925,0.0003788084],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002028104,"about_ca_system_score_gemma":0.0006374614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004495459,"about_ca_topic_score_gemma":0.00001896533,"domain_scores_codex":[0.9939478,0.001359886,0.002475644,0.001114897,0.0003586957,0.0007430716],"domain_scores_gemma":[0.9958427,0.001621358,0.001110328,0.0009898054,0.00007586091,0.0003599764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00001062464,0.001625031,0.00002765314,0.8912275,0.08953267,0.00325868,0.00000798284,7.223619e-8,2.671568e-9,0.000805378,0.0001500395,0.01335433],"study_design_scores_gemma":[0.001311255,0.0003073,0.0001680543,0.0903454,0.8546923,0.008897902,0.00001451149,0.000004135412,3.217485e-8,0.000003112124,0.04389257,0.0003634177],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000009944105,0.9896645,0.000005755039,0.000352336,0.00008154193,0.007830736,0.00006551132,0.0001058262,0.001883827],"genre_scores_gemma":[0.0002581754,0.9941172,0.0002794577,0.001254919,0.00002165484,0.003512489,0.0002854225,0.00004968016,0.0002210259],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8008822,"threshold_uncertainty_score":0.9997476,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002534044","doi":"10.1002/hon.743","title":"Radiation therapy for localized low-grade non-Hodgkin's lymphomas","year":2005,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Lymphoma; Medicine; MALT lymphoma; Radiation therapy; Follicular lymphoma; Helicobacter pylori; Marginal zone; Gastric lymphoma; Mucosa-associated lymphoid tissue; Stage (stratigraphy); Non-Hodgkin's lymphoma; Gastroenterology; Disease; Internal medicine; Pathology; Oncology; B cell; Immunology; Biology; Antibody","authors":[{"name":"Richard Tsang","is_ca":true},{"name":"Mary Gospodarowicz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08553989961677713,"gpt":0.4215549297981744,"spread":0.3360150301813973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000299667,0.0007268806,0.005106161,0.000205073,0.0001197545,0.00002249933,0.0002264903,0.001735443,0.000542451],"category_scores_gemma":[0.0001942526,0.0004336388,0.001544003,0.0002709136,0.0001767593,0.00003890874,0.00006113255,0.0002485668,0.0004089685],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001377037,"about_ca_system_score_gemma":0.001126016,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001056221,"about_ca_topic_score_gemma":0.000003338397,"domain_scores_codex":[0.9967795,0.0002587315,0.001166238,0.0008707293,0.0002526442,0.0006721448],"domain_scores_gemma":[0.9966916,0.001714837,0.000633702,0.0005283505,0.00009241959,0.000339023],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002196048,0.003060925,0.00008941552,0.00298015,0.0005737802,0.000451364,0.00001967967,2.042835e-7,2.889936e-7,0.001815559,0.01005955,0.9807295],"study_design_scores_gemma":[0.00974141,0.00265391,0.0000917799,0.001866421,0.001421046,0.0018815,0.000005854874,0.00002727802,0.00001769158,0.0001453359,0.9817556,0.0003922251],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001103969,0.9908996,0.0001268273,0.0009797504,0.0004405929,0.00490448,0.00004689208,0.0001528154,0.002338603],"genre_scores_gemma":[0.0002984169,0.9890987,0.002734732,0.001547215,0.0006792368,0.004536219,0.0007112319,0.00007630888,0.0003179958],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9803373,"threshold_uncertainty_score":0.9998115,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2621746631","doi":"10.1002/hon.2437_3","title":"INTERIM REPORT FROM A PHASE 2 MULTICENTER STUDY OF TAZEMETOSTAT, AN EZH2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMAS","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Oncology; Clinical endpoint; Interim analysis; Ixazomib; Phases of clinical research; Adverse effect; EZH2; Surrogate endpoint; Pharmacology; Refractory (planetary science); Clinical trial; Lenalidomide; Multiple myeloma","authors":[{"name":"Franck Morschhauser","is_ca":false},{"name":"Gilles Salles","is_ca":false},{"name":"Pam McKay","is_ca":false},{"name":"Hervé Tilly","is_ca":false},{"name":"Anne Dorothée Schmitt","is_ca":false},{"name":"John F. Gerecitano","is_ca":false},{"name":"Peter Johnson","is_ca":false},{"name":"Steven Le Gouill","is_ca":false},{"name":"Michael Dickinson","is_ca":false},{"name":"Christophe Fruchart","is_ca":false},{"name":"Thierry Lamy","is_ca":false},{"name":"Aristeidis Chaidos","is_ca":false},{"name":"Wojciech Jurczak","is_ca":false},{"name":"Stephen Opat","is_ca":false},{"name":"John Radford","is_ca":false},{"name":"Pier Luigi Zinzani","is_ca":false},{"name":"Sarit Assouline","is_ca":true},{"name":"Guillaume Cartron","is_ca":false},{"name":"Alicia Clawson","is_ca":false},{"name":"N. Picazio","is_ca":false},{"name":"Scott Ribich","is_ca":false},{"name":"Stephen J. Blakemore","is_ca":false},{"name":"John Larus","is_ca":false},{"name":"Harry Miao","is_ca":false},{"name":"Peter Ho","is_ca":false},{"name":"Vincent Ribrag","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03091780164131205,"gpt":0.3516476903810811,"spread":0.320729888739769,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002932874,0.0002247572,0.0005415939,0.0000635349,0.00009636719,0.00002314365,0.0003321107,0.0003689448,0.00007007532],"category_scores_gemma":[0.0004005828,0.0001566372,0.0000548075,0.00004704782,0.0001735803,0.00001542581,0.0002402379,0.0001575835,0.000003716997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004601259,"about_ca_system_score_gemma":0.0001359931,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002784412,"about_ca_topic_score_gemma":0.0009075002,"domain_scores_codex":[0.9979926,0.0002565724,0.0006747858,0.0006237236,0.0001878866,0.0002644418],"domain_scores_gemma":[0.9980131,0.00006580142,0.0007363228,0.0008908177,0.0001688299,0.0001250614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009051492,0.02084004,0.8527355,0.00002406186,0.00007524042,0.0007117746,0.0005547511,0.00001253313,0.1099398,0.000002490182,0.0001107581,0.005941505],"study_design_scores_gemma":[0.04372595,0.05616002,0.7041929,0.00005731578,0.0001020293,0.00001145077,0.0009112536,0.0001435876,0.1861034,0.00006601617,0.007953285,0.0005727664],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998085,0.00007316995,0.0002390168,0.00002711006,0.0002077549,0.0006523165,0.00002030857,0.00000850331,0.0006868452],"genre_scores_gemma":[0.9977568,0.00002546357,0.00172285,0.00005472752,0.00005920285,0.0000556043,0.0002317717,0.00002272697,0.00007084936],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1485426,"threshold_uncertainty_score":0.6387478,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2167849560","doi":"10.1002/hon.703","title":"Increasing incidence of non‐Hodgkin's lymphoma in Canada, 1970–1996: age–period–cohort analysis","year":2003,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Institute of Population and Public Health; Health Canada; University of Ottawa","funders":"","keywords":"Incidence (geometry); Medicine; Cohort; Lymphoma; Non-Hodgkin's lymphoma; Cohort effect; Cancer registry; Demography; Hodgkin lymphoma; Cohort study; Cancer; Pediatrics; Internal medicine","authors":[{"name":"Shiliang Liu","is_ca":true},{"name":"R Semenciw","is_ca":true},{"name":"Yang Mao","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01736833943235416,"gpt":0.2922388759038446,"spread":0.2748705364714904,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000475803,0.0002382369,0.001612005,0.0002383074,0.00005133771,0.00000633467,0.0001265725,0.0002483781,0.0004171484],"category_scores_gemma":[0.0007391924,0.0001759176,0.0002178821,0.0009534293,0.0001611539,0.00003760988,0.00006098693,0.0001116181,0.00001527274],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002003145,"about_ca_system_score_gemma":0.00220696,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.574537,"about_ca_topic_score_gemma":0.6718439,"domain_scores_codex":[0.9976397,0.000338094,0.0007455726,0.0004731473,0.000337009,0.0004665025],"domain_scores_gemma":[0.9983339,0.000713588,0.0002352055,0.0003805421,0.00008750982,0.0002492991],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001638461,0.0009465832,0.9848946,0.00003585891,0.000460795,0.009126955,0.00007887744,0.00002560346,0.0002947138,0.001056309,0.0001531845,0.002762726],"study_design_scores_gemma":[0.002458113,0.0004369499,0.9902827,0.00005223315,0.0007670244,0.001595462,0.0002283298,0.0001780085,0.002191653,0.00009696433,0.001550779,0.0001618221],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868458,0.0005350412,0.00002876835,0.0004345106,0.00008410474,0.0003825481,0.000005955376,0.00001718021,0.01166608],"genre_scores_gemma":[0.9956422,0.000121387,0.003292846,0.0007557367,0.00001262741,0.0001095057,0.00002213144,0.000009807458,0.00003376081],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09730691,"threshold_uncertainty_score":0.717371,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3032984305","doi":"10.1002/hon.2759","title":"Risk factors for high‐dose methotrexate associated acute kidney injury in patients with hematological malignancies","year":2020,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Methotrexate; Internal medicine; Creatinine; Acute kidney injury; Univariate analysis; Gastroenterology; Confidence interval; Adverse effect; Renal function; Hazard ratio; Surgery; Multivariate analysis","authors":[{"name":"Irina Amitai","is_ca":true},{"name":"Uri Rozovski","is_ca":false},{"name":"Reem El‐Saleh","is_ca":false},{"name":"Shai Shimony","is_ca":false},{"name":"Daniel Shepshelovich","is_ca":false},{"name":"Benaya Rozen‐Zvi","is_ca":false},{"name":"Pia Raanani","is_ca":false},{"name":"Anat Gafter‐Gvili","is_ca":false},{"name":"Ronit Gurion","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03139114837398717,"gpt":0.3225171573876341,"spread":0.2911260090136469,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004582793,0.0004647299,0.001961083,0.0001584089,0.0001325174,0.0000207768,0.0003421365,0.0009148203,0.0003663582],"category_scores_gemma":[0.01024944,0.0002801626,0.0002020961,0.0007291423,0.0004670799,0.0001008871,0.0002696641,0.0008428131,0.00008291879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008367964,"about_ca_system_score_gemma":0.0007989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004159916,"about_ca_topic_score_gemma":0.000004183015,"domain_scores_codex":[0.9960775,0.0005564394,0.0008303835,0.0008921989,0.0005794069,0.00106406],"domain_scores_gemma":[0.9962469,0.00176024,0.0004101105,0.0003033998,0.0003535543,0.0009257516],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01412907,0.002581363,0.9574769,0.0001964013,0.000727394,0.001341437,0.0004913845,0.000004677161,0.0005753173,0.003011281,0.01891069,0.0005540704],"study_design_scores_gemma":[0.04830051,0.03298555,0.8996714,0.0002244301,0.00107179,0.000153047,0.0002748306,0.001535731,0.006804226,0.002155502,0.005743769,0.001079209],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899768,0.00001504137,0.001292381,0.00561788,0.0001036605,0.001910132,0.0004416846,0.0002388455,0.0004035611],"genre_scores_gemma":[0.9864616,0.00003523869,0.008287667,0.004324198,0.00004353838,0.0002609611,0.0004626043,0.00004994684,0.00007423157],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0578055,"threshold_uncertainty_score":0.9999651,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2046069452","doi":"10.1002/hon.931","title":"The clinical relevance of <i>Wilms Tumour 1</i> (<i>WT1</i>) gene mutations in acute leukaemia","year":2009,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Foothills Medical Centre","funders":"Medical Research Council; Research Councils UK; Cancer Research UK","keywords":"Wilms' tumor; Clinical significance; Oncology; Mutation; Karyotype; Medicine; Internal medicine; Gene; Gene mutation; Wilms tumour; Cancer research; Biology; Genetics; Chromosome","authors":[{"name":"Carolyn Owen","is_ca":true},{"name":"Jude Fitzgibbon","is_ca":false},{"name":"Peter Paschka","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04421241951846455,"gpt":0.392970906873712,"spread":0.3487584873552474,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006810335,0.0003967767,0.002037948,0.00005867814,0.000101189,0.00001093727,0.0006822515,0.001835701,0.000009320338],"category_scores_gemma":[0.0004746588,0.0002224733,0.0008307226,0.0003094219,0.0006567998,0.000002705732,0.0001849095,0.000983879,0.0000386928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008286136,"about_ca_system_score_gemma":0.000894868,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004372503,"about_ca_topic_score_gemma":0.00003202567,"domain_scores_codex":[0.9962163,0.0007647361,0.001700926,0.0006714548,0.0001603195,0.0004862697],"domain_scores_gemma":[0.9977696,0.0006436153,0.0008720825,0.0004911319,0.00008949927,0.000134066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001647466,0.0003363527,0.00003588022,0.000653585,0.0004381294,0.0003937872,0.000007514785,0.0000181898,0.0002862735,0.0009745514,0.007219453,0.9894716],"study_design_scores_gemma":[0.0005059888,0.0009435563,0.00002224786,0.0006718927,0.0003711071,0.000892821,0.000007823153,0.000002876889,0.0002801024,0.0005201635,0.9955075,0.0002739068],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001133969,0.9951099,0.00006710873,0.000278028,0.0004486908,0.0005967593,0.00002769559,0.00001564112,0.002322249],"genre_scores_gemma":[0.0005410544,0.9973795,0.0007583721,0.0003010551,0.0001777478,0.0001341323,0.0001720558,0.00002675361,0.0005093766],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9891976,"threshold_uncertainty_score":0.9994601,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3109601420","doi":"10.1002/hon.2828","title":"Obinutuzumab‐related adverse events: A systematic review and meta‐analysis","year":2020,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Obinutuzumab; Medicine; Rituximab; Internal medicine; Chronic lymphocytic leukemia; Adverse effect; Relative risk; Oncology; Meta-analysis; Hazard ratio; Follicular lymphoma; Lymphoma; Leukemia; Confidence interval","authors":[{"name":"Irina Amitai","is_ca":true},{"name":"Anat Gafter‐Gvili","is_ca":false},{"name":"Liat Shargian","is_ca":false},{"name":"Pia Raanani","is_ca":false},{"name":"Ronit Gurion","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1180247417335613,"gpt":0.4309193846730987,"spread":0.3128946429395374,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001217518,0.0008758367,0.03048855,0.000401459,0.00008026772,0.000007373966,0.0004898679,0.001431695,0.002955173],"category_scores_gemma":[0.002705915,0.0004793421,0.00526376,0.00231399,0.0003251389,0.00004587167,0.0005522206,0.00135688,0.001352361],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01319466,"about_ca_system_score_gemma":0.009900045,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002534364,"about_ca_topic_score_gemma":0.000005837636,"domain_scores_codex":[0.9924899,0.002178224,0.002764747,0.001240945,0.0006152274,0.0007109033],"domain_scores_gemma":[0.9944242,0.002426579,0.001171306,0.001060519,0.0001692283,0.0007481881],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.000011784,0.00009203313,8.813767e-8,0.7877951,0.2065331,0.004042532,0.00001451037,1.246883e-7,7.339673e-9,0.0005840717,0.0004153032,0.0005112987],"study_design_scores_gemma":[0.001228379,0.0004064437,3.232651e-8,0.03969701,0.7434517,0.0129689,0.00001165209,0.00007072331,2.848982e-8,0.00004740832,0.2018189,0.0002988012],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[4.139182e-7,0.9894714,0.00002176867,0.0009871715,0.00003936444,0.00745236,0.00003768606,0.0001708529,0.001818929],"genre_scores_gemma":[0.00001457405,0.9938449,0.0003941227,0.001842508,0.00002260538,0.002252979,0.0001824206,0.00006186556,0.001384039],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7480981,"threshold_uncertainty_score":0.9998646,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4383998685","doi":"10.1002/hon.3202","title":"Diffuse large B‐cell lymphoma","year":2023,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Vincristine; Lymphoma; CHOP; Prednisone; Oncology; Clinical trial; Internal medicine; Intensive care medicine; Cyclophosphamide; Chemotherapy","authors":[{"name":"Allison Barraclough","is_ca":false},{"name":"Eliza A. Hawkes","is_ca":false},{"name":"Laurie H. Sehn","is_ca":true},{"name":"Sonali M. Smith","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1736930225114751,"gpt":0.4571691031232177,"spread":0.2834760806117427,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008507273,0.0006533656,0.005796941,0.0004236603,0.0001114289,0.0000240089,0.0005279249,0.002286305,0.00753869],"category_scores_gemma":[0.0006144973,0.0004237265,0.001365963,0.0008897153,0.0002849295,0.00002282153,0.0005981798,0.001114336,0.01169266],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007992364,"about_ca_system_score_gemma":0.001265442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007356631,"about_ca_topic_score_gemma":0.00001018708,"domain_scores_codex":[0.9953087,0.0007435638,0.001168261,0.0009862733,0.0005457901,0.001247417],"domain_scores_gemma":[0.9956437,0.002390917,0.0003622641,0.0009348054,0.0001074368,0.0005609021],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001317015,0.006609725,0.00001159063,0.02827847,0.0003464491,0.01146924,0.0000339808,4.117998e-9,0.000006176967,0.001687427,0.01999978,0.9314255],"study_design_scores_gemma":[0.005182715,0.001010909,0.00000430967,0.002519562,0.0007302252,0.004059354,0.00002826334,0.000004907521,0.0000048947,0.0001675505,0.9859245,0.0003627622],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000784785,0.9527943,0.00001462678,0.0002714672,0.0004311446,0.00200666,0.00004567654,0.0004996274,0.04385804],"genre_scores_gemma":[0.000009796842,0.9519312,0.0002108699,0.0004586892,0.0004114425,0.0006444574,0.0002549996,0.0001577614,0.04592073],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9659247,"threshold_uncertainty_score":0.9998215,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2031242160","doi":"10.1002/hon.902","title":"Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy","year":2009,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Myelofibrosis; Internal medicine; Gastroenterology; Splenectomy; White blood cell; Blood transfusion; Anemia; Surgery; Bone marrow","authors":[{"name":"Heather A. Leitch","is_ca":true},{"name":"Jocelyn M. Chase","is_ca":true},{"name":"Trisha A. Goodman","is_ca":true},{"name":"Hatoon Ezzat","is_ca":true},{"name":"M. D. Rollins","is_ca":true},{"name":"Dominic H.C. Wong","is_ca":true},{"name":"Maha A. Badawi","is_ca":true},{"name":"Chantal S. Leger","is_ca":true},{"name":"Khaled M. A. Ramadan","is_ca":true},{"name":"Michael J. Barnett","is_ca":true},{"name":"Lynda Foltz","is_ca":true},{"name":"Linda M. Vickars","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01549096739603593,"gpt":0.257920360962542,"spread":0.2424293935665061,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002237349,0.0002924154,0.0008420448,0.0001113325,0.00008956063,0.00001257614,0.00007606205,0.0003836583,0.0002173461],"category_scores_gemma":[0.00004941195,0.0001853481,0.00009538943,0.0002115044,0.00005497098,0.00008141068,0.00001864085,0.0003245149,0.00001031],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000266743,"about_ca_system_score_gemma":0.0001120016,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002633252,"about_ca_topic_score_gemma":0.00008136038,"domain_scores_codex":[0.9980072,0.0002383652,0.0005057054,0.0005502768,0.0002987908,0.0003996623],"domain_scores_gemma":[0.9990547,0.0002937171,0.0001705999,0.0002188568,0.0001043164,0.0001578432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003773834,0.009755543,0.9445922,0.00005091207,0.00004725217,0.0002090013,0.0003114993,0.000008308778,0.0174866,0.0001250468,0.00003127114,0.02360852],"study_design_scores_gemma":[0.01686127,0.01166766,0.9525262,0.00007779795,0.00009097637,0.00004584302,0.00003647194,0.00003827144,0.01817749,0.00008801003,0.0001812794,0.0002087439],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900916,0.000249285,0.00008906368,0.002142993,0.00008206262,0.001439297,0.00000458505,0.00007093245,0.005830238],"genre_scores_gemma":[0.99527,0.0008115855,0.002738675,0.0008064822,0.00003714942,0.0001389464,0.0001182265,0.0000172493,0.00006173744],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02339977,"threshold_uncertainty_score":0.7558275,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2951473081","doi":"10.1002/hon.127_2629","title":"HIGH RATE OF DURABLE COMPLETE REMISSION IN FOLLICULAR LYMPHOMA AFTER CD19 CAR‐T CELL IMMUNOTHERAPY","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Follicular lymphoma; Chemoimmunotherapy; Fludarabine; Internal medicine; Lymphoma; Cyclophosphamide; Gastroenterology; Immunotherapy; Oncology; Rituximab; Immunology; Surgery; Chemotherapy; Cancer","authors":[{"name":"Alexandre V. Hirayama","is_ca":false},{"name":"Jordan Gauthier","is_ca":false},{"name":"Kevin A. Hay","is_ca":true},{"name":"Jenna Voutsinas","is_ca":false},{"name":"Qian Wu","is_ca":false},{"name":"Alyssa Sheih","is_ca":false},{"name":"Janaki Purushe","is_ca":false},{"name":"Barbara S. Pender","is_ca":false},{"name":"Reed M. Hawkins","is_ca":false},{"name":"Aesha Vakil","is_ca":false},{"name":"Ngan Thi Thuy Phi","is_ca":false},{"name":"Rachel N. Steinmetz","is_ca":false},{"name":"Stanley R. Riddell","is_ca":false},{"name":"David G. Maloney","is_ca":false},{"name":"Cameron J. Turtle","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02523600938608766,"gpt":0.3108993511486213,"spread":0.2856633417625337,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006781083,0.0002227523,0.001232239,0.0001778057,0.00002516497,0.000006754823,0.0002026181,0.0004744375,0.013545],"category_scores_gemma":[0.00007396097,0.0001596912,0.0002126388,0.0003452715,0.0001820964,0.00004115732,0.0001068356,0.0003152755,0.000339658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003015262,"about_ca_system_score_gemma":0.0002121948,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002027899,"about_ca_topic_score_gemma":0.00001310781,"domain_scores_codex":[0.9976568,0.0004540091,0.0006288846,0.0004558406,0.0002633243,0.0005411081],"domain_scores_gemma":[0.9984639,0.0005552584,0.0001588319,0.0005498828,0.0001182454,0.0001538529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.006236092,0.00104692,0.03299004,0.0002265551,0.00005207307,0.001173649,0.0001663291,0.00000964568,0.953873,0.0007050483,0.000440517,0.003080071],"study_design_scores_gemma":[0.03882198,0.008409007,0.1507874,0.0004194185,0.00006850138,0.001359586,0.000422155,0.0007007931,0.5016335,0.003274791,0.293384,0.0007189706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886222,0.0009476544,0.00002697024,0.001395384,0.0001666922,0.0009196547,0.000005129561,0.00004066188,0.007875661],"genre_scores_gemma":[0.9919688,0.0004366743,0.001169065,0.001059848,0.00003425819,0.00008574766,0.00001951454,0.00003089964,0.00519518],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4522396,"threshold_uncertainty_score":0.9873567,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2515380104","doi":"10.1002/hon.2339","title":"Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B‐cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group‐37 study","year":2016,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Cancer Research UK; National Cancer Institute; National Cancer Research Institute","keywords":"Medicine; Concordance; Positron emission tomography; Lymphoma; Nuclear medicine; Radiology; Radiation therapy; Interim; Clinical endpoint; Mediastinum; Clinical trial; Medical physics; Internal medicine","authors":[{"name":"Luca Ceriani","is_ca":false},{"name":"Sally F. Barrington","is_ca":false},{"name":"Alberto Biggi","is_ca":false},{"name":"Bogdan Małkowski","is_ca":false},{"name":"Ur Metser","is_ca":true},{"name":"Annibale Versari","is_ca":false},{"name":"Maurizio Martelli","is_ca":false},{"name":"Andrew Davies","is_ca":false},{"name":"Peter Johnson","is_ca":false},{"name":"Emanuele Zucca","is_ca":false},{"name":"Stéphane Chauvie","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.110996917102976,"gpt":0.3821411964883498,"spread":0.2711442793853738,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002476722,0.00075032,0.004211206,0.0003891095,0.0001148397,0.00003201814,0.001452852,0.0003553864,0.00013521],"category_scores_gemma":[0.0002948117,0.0002730274,0.00160346,0.001316964,0.0002914795,0.00007222538,0.0007116789,0.000365084,0.000007604808],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001227648,"about_ca_system_score_gemma":0.0004342651,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001603629,"about_ca_topic_score_gemma":0.0003035703,"domain_scores_codex":[0.9921024,0.003010495,0.002446939,0.0009819538,0.0009083109,0.000549893],"domain_scores_gemma":[0.9952372,0.002276311,0.001242897,0.001030207,0.00009871222,0.0001147169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0002880487,0.02959066,0.04360156,0.003178072,0.002366239,0.001187815,0.004274722,9.836878e-8,0.00001110184,0.00002946087,0.0002788246,0.9151934],"study_design_scores_gemma":[0.02564608,0.01239531,0.6657792,0.07219043,0.0196875,0.002163377,0.01580052,0.00001794377,0.00001312859,0.00004187482,0.1850716,0.001193021],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1329784,0.8585909,0.00000648366,0.001186811,0.0003930026,0.005922087,0.0000163024,0.00002354931,0.0008824453],"genre_scores_gemma":[0.3728907,0.6240312,0.00006300448,0.0008255515,0.00008514455,0.002006113,0.00004839934,0.00002396346,0.00002582639],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9140004,"threshold_uncertainty_score":0.9999722,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3158953552","doi":"10.1002/hon.2875","title":"Safety and efficacy of autologous whole cell vaccines in hematologic malignancies: A systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital; Western University","funders":"Ottawa Hospital Anesthesia Alternate Funds Association; Ottawa Hospital; University of Ottawa; Terry Fox Research Institute; Cancer Research Society; American Society of Hematology","keywords":"Medicine; Adverse effect; Internal medicine; Clinical trial; Vaccination; Oncology; Meta-analysis; Immunology","authors":[{"name":"Donald Bastin","is_ca":true},{"name":"S. Khan","is_ca":true},{"name":"Joshua Montroy","is_ca":true},{"name":"Michael A. Kennedy","is_ca":true},{"name":"Nicole Forbes","is_ca":true},{"name":"Andre B. Martel","is_ca":true},{"name":"Laura Baker","is_ca":true},{"name":"Louise Gresham","is_ca":true},{"name":"Dominique Boucher","is_ca":true},{"name":"Boaz Wong","is_ca":true},{"name":"Risa Shorr","is_ca":true},{"name":"Jean‐Simon Diallo","is_ca":true},{"name":"Dean Fergusson","is_ca":true},{"name":"Manoj M. Lalu","is_ca":true},{"name":"Rebecca C. Auer","is_ca":true},{"name":"Natasha Kekre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04563399071705088,"gpt":0.3339401710395105,"spread":0.2883061803224596,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001635737,0.0009633084,0.02576906,0.000632302,0.0001413093,0.00001754631,0.0005676189,0.001980665,0.0008772633],"category_scores_gemma":[0.00121771,0.0005889431,0.001934494,0.001338877,0.0006386891,0.00006340969,0.000480152,0.0009488281,0.00007166144],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009003984,"about_ca_system_score_gemma":0.000327937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002714127,"about_ca_topic_score_gemma":0.00001843393,"domain_scores_codex":[0.988741,0.006092587,0.003327958,0.001061397,0.00007249883,0.0007044953],"domain_scores_gemma":[0.9900233,0.006986297,0.00190283,0.0009026187,0.0001314025,0.00005355984],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0001399546,0.0009474994,0.000007362264,0.897536,0.09698039,0.0004364529,0.000159179,4.421722e-7,0.00006015429,0.001444851,0.0001734243,0.002114312],"study_design_scores_gemma":[0.001488859,0.0008087808,0.00001697251,0.03772194,0.7482015,0.007252413,0.0001566717,4.137971e-7,0.00005926593,0.00003654334,0.2033478,0.0009088294],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007980446,0.9964839,0.00003023082,0.0002605275,0.00008749781,0.002736698,0.00009418094,0.00006422562,0.0001629793],"genre_scores_gemma":[0.0003348175,0.9972442,0.0001571019,0.0003898412,0.000002728182,0.0005711698,0.0001983863,0.00003601679,0.001065752],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.859814,"threshold_uncertainty_score":0.9996562,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4380078597","doi":"10.1002/hon.3196_lba4","title":"TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Refractory (planetary science); Follicular lymphoma; Gastroenterology; Clinical endpoint; Oncology; Rituximab; Phases of clinical research; Neutropenia; Lymphoma; Surgery; Clinical trial; Chemotherapy","authors":[{"name":"Franck Morschhauser","is_ca":false},{"name":"Saurabh Dahiya","is_ca":false},{"name":"M. Lia Palomba","is_ca":false},{"name":"Juan Luis Reguera Ortega","is_ca":false},{"name":"John Kuruvilla","is_ca":true},{"name":"Ulrich Jäger","is_ca":false},{"name":"Guillaume Cartron","is_ca":false},{"name":"Koji Izutsu","is_ca":false},{"name":"Martin Dreyling","is_ca":false},{"name":"Brad S. Kahl","is_ca":false},{"name":"Hervé Ghesquières","is_ca":false},{"name":"Kirit M. Ardeshna","is_ca":false},{"name":"Hideki Goto","is_ca":false},{"name":"Anna Maria Barbui","is_ca":false},{"name":"Jeremy S. Abramson","is_ca":false},{"name":"Peter Borchmann","is_ca":false},{"name":"Isabelle Fleury","is_ca":true},{"name":"Stephan Mielke","is_ca":false},{"name":"Thalia A. Farazi","is_ca":false},{"name":"Omotayo Fasan","is_ca":false},{"name":"James Lymp","is_ca":false},{"name":"Min Vedal","is_ca":false},{"name":"Ryuichi Nishii","is_ca":false},{"name":"Ariel Avilion","is_ca":false},{"name":"J. Papuga","is_ca":false},{"name":"Loretta J. Nastoupil","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02644501582058063,"gpt":0.3272590848480463,"spread":0.3008140690274657,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006363366,0.0002677882,0.0006075163,0.0002272078,0.00008170076,0.00001189811,0.0003499743,0.0004776648,0.00007322975],"category_scores_gemma":[0.0003976165,0.0002044285,0.0001279874,0.0006217282,0.0002193358,0.000009501106,0.0001551377,0.0002140716,0.00006313284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007022555,"about_ca_system_score_gemma":0.0001897462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005808047,"about_ca_topic_score_gemma":0.000235839,"domain_scores_codex":[0.9970989,0.0005020599,0.0007201008,0.0007081418,0.0004153589,0.0005554046],"domain_scores_gemma":[0.9987861,0.0001100767,0.0002112843,0.0005197243,0.0001949433,0.0001778532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08198649,0.08883967,0.4771866,0.0005412765,0.00102159,0.004909494,0.002732047,0.0006704924,0.2213532,0.0006394734,0.01889161,0.1012281],"study_design_scores_gemma":[0.1840248,0.09264906,0.4472336,0.0001278115,0.0001362658,0.0001165417,0.002230932,0.0006037558,0.09380366,0.0001971066,0.1773258,0.001550612],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966496,0.0001455492,0.00005737154,0.0002793505,0.00008599593,0.001156665,0.00005582815,0.00004252832,0.001527104],"genre_scores_gemma":[0.9984331,0.0001234515,0.0002129789,0.0001085554,0.00003700068,0.0001773849,0.0003740444,0.00002911931,0.0005043814],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1584342,"threshold_uncertainty_score":0.8336352,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2128518863","doi":"10.1002/hon.2265","title":"Associations between statin use and non‐Hodgkin lymphoma (NHL) risk and survival: a meta‐analysis","year":2015,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"CancerCare Manitoba; University of Manitoba; Winnipeg Regional Health Authority","funders":"Research Manitoba","keywords":"Medicine; Internal medicine; Hazard ratio; Statin; Lymphoma; Odds ratio; Non-Hodgkin's lymphoma; Meta-analysis; Oncology; Incidence (geometry); Epidemiology; Confidence interval","authors":[{"name":"Xibiao Ye","is_ca":true},{"name":"Ayat Mneina","is_ca":true},{"name":"James B. Johnston","is_ca":true},{"name":"Salaheddin M. Mahmud","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1279351761986888,"gpt":0.3888846451250296,"spread":0.2609494689263407,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001232086,0.0005672268,0.005717651,0.0001991301,0.0001429906,0.00006898215,0.0002481597,0.001470365,0.0000352572],"category_scores_gemma":[0.0008606342,0.0004095222,0.00113728,0.0004087868,0.0002984922,0.000008530989,0.0004001305,0.0003072407,0.00001171047],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007348158,"about_ca_system_score_gemma":0.0004889859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003084246,"about_ca_topic_score_gemma":0.0006375838,"domain_scores_codex":[0.9959728,0.001448094,0.0009126919,0.0009708721,0.0002120503,0.0004835516],"domain_scores_gemma":[0.9972042,0.0008496682,0.0008920156,0.000493379,0.0001963381,0.0003643885],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008649434,0.0005897841,0.007928316,0.001899773,0.2154138,0.00001524365,0.000188435,0.000004009682,0.00001172101,0.0009320262,0.03277267,0.7401577],"study_design_scores_gemma":[0.0004728167,0.0002285373,0.000989405,0.00001768917,0.1390472,0.00003648775,0.00001646479,0.000001688242,0.000001485221,0.0001132922,0.8586899,0.0003850226],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00125509,0.9945299,0.0006283208,0.0000553782,0.0007176634,0.0005877757,0.001918634,0.00002832522,0.000278929],"genre_scores_gemma":[0.0003016023,0.994341,0.001643997,0.0001081258,0.001619363,0.0002005405,0.001442906,0.00004211134,0.0003003957],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8259172,"threshold_uncertainty_score":0.9998357,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4380078644","doi":"10.1002/hon.3163_5","title":"NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children; McGill University Health Centre","funders":"National Cancer Institute; Agenzia Italiana del Farmaco, Ministero della Salute; National Institutes of Health; Seagen; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Neutropenia; Clinical endpoint; Oncology; Progression-free survival; Phases of clinical research; Randomized controlled trial; Chemotherapy; Lymphoma; Hodgkin lymphoma","authors":[{"name":"Alex F. Herrera","is_ca":false},{"name":"Michael LeBlanc","is_ca":false},{"name":"Sharon M. Castellino","is_ca":false},{"name":"Huilin Li","is_ca":false},{"name":"Sarah C. Rutherford","is_ca":false},{"name":"Andrew M. Evens","is_ca":false},{"name":"Kelly Davison","is_ca":true},{"name":"Angela Punnett","is_ca":true},{"name":"David Hodgson","is_ca":true},{"name":"Susan K. Parsons","is_ca":false},{"name":"Sairah Ahmed","is_ca":false},{"name":"Carla Casulo","is_ca":false},{"name":"Nancy L. Bartlett","is_ca":false},{"name":"Joseph M. Tuscano","is_ca":false},{"name":"Matthew Mei","is_ca":false},{"name":"Brian Hess","is_ca":false},{"name":"Ryan Jacobs","is_ca":false},{"name":"Hayder Saeed","is_ca":false},{"name":"Pallawi Torka","is_ca":false},{"name":"Boyu Hu","is_ca":false},{"name":"Craig H. Moskowitz","is_ca":false},{"name":"Simran Kaur","is_ca":false},{"name":"Gaurav Goyal","is_ca":false},{"name":"Christopher J. Forlenza","is_ca":false},{"name":"Andrew Doan","is_ca":false},{"name":"Adam J. Lamble","is_ca":false},{"name":"Pankaj Kumar","is_ca":false},{"name":"S. Chowdhury","is_ca":false},{"name":"Brett T. Brinker","is_ca":false},{"name":"Neeti Sharma","is_ca":false},{"name":"Anurag K. Singh","is_ca":false},{"name":"Kristie A. Blum","is_ca":false},{"name":"Anamarija M. Perry","is_ca":false},{"name":"Alexandra E. Kovach","is_ca":false},{"name":"Louis S. Constine","is_ca":false},{"name":"Laura Shields","is_ca":false},{"name":"Anca Prica","is_ca":true},{"name":"Richard F. Little","is_ca":false},{"name":"Margaret A. Shipp","is_ca":false},{"name":"Michael Crump","is_ca":true},{"name":"Brad S. Kahl","is_ca":false},{"name":"John P. Leonard","is_ca":false},{"name":"Sonali M. Smith","is_ca":false},{"name":"Joo Y. Song","is_ca":false},{"name":"Kara M. Kelly","is_ca":false},{"name":"Jonathan W. Friedberg","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0415212648976049,"gpt":0.3670687384005554,"spread":0.3255474735029505,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006656519,0.0004824359,0.002043002,0.0004013284,0.0001086949,0.00001975885,0.0004535768,0.0005197356,0.0001486778],"category_scores_gemma":[0.001780342,0.000351919,0.0002796036,0.001150619,0.0003329672,0.0000871521,0.0005809276,0.0002304317,0.0004464971],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006870906,"about_ca_system_score_gemma":0.000557246,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002695765,"about_ca_topic_score_gemma":0.0005837991,"domain_scores_codex":[0.9954899,0.0003849448,0.001400916,0.001042865,0.0006729266,0.001008455],"domain_scores_gemma":[0.9964503,0.001456201,0.0004713145,0.0009292169,0.0001990711,0.0004939109],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0489295,0.04119636,0.3990979,0.001534481,0.0009249682,0.0275306,0.003086466,0.0001461115,0.03232139,0.01893683,0.04674586,0.3795495],"study_design_scores_gemma":[0.08250049,0.01442177,0.8225558,0.0009042452,0.0002097708,0.0005242618,0.002071132,0.0009698194,0.0195415,0.001474816,0.05398391,0.0008424798],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818264,0.0003789559,0.00001049847,0.006767494,0.000565527,0.001809971,0.0001238545,0.0003235413,0.008193735],"genre_scores_gemma":[0.9951023,0.000188056,0.002235223,0.0005950976,0.00007596634,0.0006482776,0.0002049382,0.00004325894,0.0009068412],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4234579,"threshold_uncertainty_score":0.9998933,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2411200550","doi":"10.1002/hon.2305","title":"<i>FCGR3A</i>/<i>2A</i> polymorphisms and diffuse large B‐cell lymphoma outcome treated with immunochemotherapy: a meta‐analysis on 1134 patients from two prospective cohorts","year":2016,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Fondation de France; National Cancer Institute; Fondation Philippe Wiener - Maurice Anspach","keywords":"Medicine; Internal medicine; Rituximab; Hazard ratio; Oncology; Single-nucleotide polymorphism; Lymphoma; Diffuse large B-cell lymphoma; Immunology; Genotype; Confidence interval; Biology; Gene; Genetics","authors":[{"name":"Hervé Ghesquières","is_ca":false},{"name":"Beth R. Larrabee","is_ca":false},{"name":"Corinne Haïoun","is_ca":false},{"name":"Brian K. Link","is_ca":false},{"name":"Aurélie Verney","is_ca":false},{"name":"Susan L. Slager","is_ca":false},{"name":"Nicolas Ketterer","is_ca":false},{"name":"Stephen M. Ansell","is_ca":false},{"name":"Richard Delarue","is_ca":false},{"name":"Matthew J. Maurer","is_ca":false},{"name":"Olivier Fitoussi","is_ca":false},{"name":"Thomas M. Habermann","is_ca":false},{"name":"Frédéric Peyrade","is_ca":false},{"name":"Ahmet Doǧan","is_ca":false},{"name":"Thierry Jo Molina","is_ca":false},{"name":"Anne J. Novak","is_ca":false},{"name":"Hervé Tilly","is_ca":false},{"name":"James R. Cerhan","is_ca":false},{"name":"Gilles Salles","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04268589500698621,"gpt":0.3397128301533769,"spread":0.2970269351463907,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002081544,0.001412317,0.01202841,0.0004263931,0.0001797863,0.00004448539,0.0002621374,0.001011198,0.0006702726],"category_scores_gemma":[0.00006503501,0.0006445731,0.002500493,0.0006948351,0.000338952,0.00005945204,0.0001739859,0.0003047804,0.0002510668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001024136,"about_ca_system_score_gemma":0.0003365963,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002178487,"about_ca_topic_score_gemma":0.00006589392,"domain_scores_codex":[0.9947715,0.0006152137,0.001386241,0.00179895,0.0005410801,0.000886969],"domain_scores_gemma":[0.995351,0.001754445,0.001140099,0.001080998,0.0001705023,0.0005030013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002424206,0.05805694,0.3831681,0.001893073,0.3611238,0.006599711,0.000147936,5.955762e-8,0.000001256877,0.001366345,0.0004888441,0.1847297],"study_design_scores_gemma":[0.06089443,0.007250299,0.01898987,0.001546925,0.5741005,0.0005158825,0.00001689833,0.000002026271,0.00008660187,0.0001566922,0.3349839,0.001456031],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0245736,0.9683638,0.00001451178,0.0002836831,0.00008298149,0.003503875,0.0008597384,0.0001892534,0.00212852],"genre_scores_gemma":[0.06189877,0.9327987,0.0004976818,0.001385188,0.00008157529,0.001969974,0.0007128876,0.0001259243,0.0005292716],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3641783,"threshold_uncertainty_score":0.9998627,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3125135564","doi":"10.1002/hon.2838","title":"Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study","year":2021,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Spinal Cord Injury BC; BC Cancer Agency","funders":"Takeda Oncology","keywords":"Medicine; Dacarbazine; ABVD; Internal medicine; Neutropenia; Brentuximab vedotin; Hazard ratio; Vinblastine; Gastroenterology; Population; Febrile neutropenia; Subgroup analysis; Adverse effect; Surgery; Lymphoma; Oncology; Confidence interval; Chemotherapy; Vincristine; Hodgkin lymphoma; Cyclophosphamide","authors":[{"name":"Martin Hutchings","is_ca":false},{"name":"John Radford","is_ca":false},{"name":"Stephen M. Ansell","is_ca":false},{"name":"Árpád Illés","is_ca":false},{"name":"Anna Sureda","is_ca":false},{"name":"Joseph M. Connors","is_ca":true},{"name":"Alice Šýkorová","is_ca":false},{"name":"Hirohiko Shibayama","is_ca":false},{"name":"Jeremy S. Abramson","is_ca":false},{"name":"Neil Chua","is_ca":true},{"name":"Jonathan W. Friedberg","is_ca":false},{"name":"Jan Kořen","is_ca":false},{"name":"Ann S. LaCasce","is_ca":false},{"name":"Lysiane Molina","is_ca":false},{"name":"Gerald Engley","is_ca":false},{"name":"Keenan Fenton","is_ca":false},{"name":"Hina Jolin","is_ca":false},{"name":"Rachael Liu","is_ca":false},{"name":"Ashish Gautam","is_ca":false},{"name":"Andrea Gallamini","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0133778787264279,"gpt":0.2685635926708242,"spread":0.2551857139443963,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001865193,0.0003587554,0.00186421,0.0001580925,0.00008816543,0.00001816292,0.0001565996,0.0002559416,0.0002037854],"category_scores_gemma":[0.0005580991,0.0001982454,0.0001653167,0.001036199,0.0002585772,0.00005799122,0.0002751891,0.0002241853,0.000006784645],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004138312,"about_ca_system_score_gemma":0.0002091673,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000477788,"about_ca_topic_score_gemma":0.002096828,"domain_scores_codex":[0.9968079,0.0005832513,0.0008317492,0.0008473505,0.000517333,0.0004124223],"domain_scores_gemma":[0.9966564,0.001856282,0.0004402359,0.0005710644,0.0002897727,0.0001862325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003751106,0.02109145,0.9615647,0.00001723558,0.001506208,0.0005437651,0.0003976571,0.00004877666,0.0000100029,0.0002701522,0.0001287941,0.0106702],"study_design_scores_gemma":[0.04238446,0.005688313,0.9479214,0.00005395979,0.002419426,0.000006432897,0.0004341684,0.0002139848,0.0002145636,0.00004456614,0.000435139,0.0001835668],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974364,0.000410108,0.00003004707,0.0004624007,0.00008648419,0.001121697,0.0001751774,0.00003262304,0.0002450795],"genre_scores_gemma":[0.9979759,0.000129102,0.0009423158,0.0002798637,0.00002288806,0.0001807008,0.0004196858,0.00001937051,0.00003017788],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03863336,"threshold_uncertainty_score":0.8084211,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2164571519","doi":"10.1002/hon.2251","title":"Concomitant high expression of Toll‐like receptor (TLR) and B‐cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma","year":2015,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Calgary Laboratory Services; University of Alberta; Alberta Cancer Foundation; University of Calgary","funders":"Alberta Cancer Foundation; Calgary Laboratory Services","keywords":"breakpoint cluster region; Cancer research; Syk; Biology; B-cell receptor; Mantle cell lymphoma; Toll-like receptor; Signal transduction; TLR7; Bruton's tyrosine kinase; TLR9; Receptor; Immunology; B cell; Gene expression; Cell biology; Innate immune system; Immune system; Gene; Lymphoma; Genetics; Tyrosine kinase; Antibody","authors":[{"name":"Ariz Akhter","is_ca":true},{"name":"Lesley Street","is_ca":true},{"name":"Sunita Ghosh","is_ca":true},{"name":"Bruce F. Burns","is_ca":true},{"name":"Ghaleb Elyamany","is_ca":false},{"name":"Meer‐Taher Shabani‐Rad","is_ca":true},{"name":"Douglas A. Stewart","is_ca":true},{"name":"Adnan Mansoor","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08521364045476884,"gpt":0.3416249336855472,"spread":0.2564112932307784,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004625045,0.0002416717,0.001133695,0.00009676503,0.00006124521,0.00001265588,0.0001376587,0.0005357831,0.0001674771],"category_scores_gemma":[0.0002534552,0.0001692354,0.0001429956,0.0001557166,0.0003728294,0.00004640852,0.0001591116,0.0001575259,0.0001048281],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002663059,"about_ca_system_score_gemma":0.000391123,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005768371,"about_ca_topic_score_gemma":0.00001402821,"domain_scores_codex":[0.9975752,0.0003349064,0.0009924083,0.0005498994,0.000193071,0.0003545662],"domain_scores_gemma":[0.9976439,0.001143243,0.0003401678,0.0003127962,0.0001422909,0.000417537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004111369,0.03332616,0.7193285,0.0004447609,0.0001442185,0.001133224,0.0009559239,0.0000195389,0.1533952,0.01080764,0.05957221,0.01676123],"study_design_scores_gemma":[0.07926635,0.01762091,0.1622082,0.0007994767,0.0005790343,0.001006432,0.002030469,0.0003703533,0.5883537,0.00500281,0.1415524,0.001209846],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990423,0.001701996,0.0001390083,0.003888252,0.0002264409,0.0006236944,0.00002513196,0.00005017575,0.002922316],"genre_scores_gemma":[0.9820789,0.0007447392,0.0161326,0.0006152245,0.00006134951,0.0001585041,0.00006105186,0.00001893827,0.0001286895],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5571203,"threshold_uncertainty_score":0.690122,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2622897264","doi":"10.1002/hon.2437_57","title":"DYNAMO: a PHASE 2 STUDY DEMONSTRATING THE CLINICAL ACTIVITY OF DUVELISIB IN PATIENTS WITH DOUBLE‐REFRACTORY INDOLENT NON‐HODGKIN LYMPHOMA","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Cégep de l'Outaouais; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Refractory (planetary science); Gastroenterology; Clinical endpoint; Regimen; Lymphoma; Surgery; Oncology; Clinical trial","authors":[{"name":"Pier Luigi Zinzani","is_ca":false},{"name":"Nina D. Wagner‐Johnston","is_ca":false},{"name":"Carole B. Miller","is_ca":false},{"name":"Kirit M. Ardeshna","is_ca":false},{"name":"S. Tertreault","is_ca":false},{"name":"Sarit Assouline","is_ca":true},{"name":"Jiřı́ Mayer","is_ca":false},{"name":"Francesco Passamonti","is_ca":false},{"name":"Scott D. Lunin","is_ca":false},{"name":"Andrew R. Pettitt","is_ca":false},{"name":"Zsolt Nagy","is_ca":false},{"name":"Olivier Tournilhac","is_ca":false},{"name":"Karim Abou-Nassar","is_ca":true},{"name":"Michael Crump","is_ca":true},{"name":"E. Jacobsen","is_ca":false},{"name":"Sven de Vos","is_ca":false},{"name":"Hagop Youssoufian","is_ca":false},{"name":"Jane Porter","is_ca":false},{"name":"Ian W. Flinn","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08567979818774954,"gpt":0.4524975538175632,"spread":0.3668177556298137,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001823309,0.0002580118,0.001320565,0.00009632065,0.00023796,0.00002908519,0.0005967217,0.0004251308,0.00008437331],"category_scores_gemma":[0.001500435,0.0001378384,0.0001469329,0.0001546385,0.001222913,0.0001243522,0.0004821086,0.0007025059,0.00002175932],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002761696,"about_ca_system_score_gemma":0.004680143,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005323234,"about_ca_topic_score_gemma":0.0005326066,"domain_scores_codex":[0.9967024,0.0005496527,0.000916992,0.0005906924,0.0006719273,0.0005683666],"domain_scores_gemma":[0.9961205,0.001512048,0.0007369809,0.001169074,0.0002237257,0.0002376397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02180785,0.03301502,0.8721244,0.0001047856,0.0002269145,0.001768231,0.0005467299,0.000003355202,0.00007403558,0.0001399089,0.0001152306,0.07007354],"study_design_scores_gemma":[0.1696244,0.01930376,0.8082384,0.0001186052,0.000106617,0.0001489619,0.0004254373,0.001384913,0.0002814768,0.00002502679,0.000181386,0.0001609761],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935776,0.00002247673,0.00004580255,0.0006035794,0.0001442398,0.002242478,0.000004384623,0.00002468513,0.003334774],"genre_scores_gemma":[0.9992801,0.00001251256,0.000291302,0.0001524638,0.00006347299,0.0001474556,0.000004809089,0.00001947565,0.00002841996],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1478166,"threshold_uncertainty_score":0.8302373,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3178904653","doi":"10.1002/hon.2898","title":"Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low‐, intermediate‐1‐, intermediate‐2‐, and high‐risk myelofibrosis in JUMP, a Phase 3b, expanded‐access study","year":2021,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"Novartis Pharma; Celgene","keywords":"Ruxolitinib; International Prognostic Scoring System; Medicine; Myelofibrosis; Internal medicine; Adverse effect; Anemia; Clinical endpoint; Janus kinase inhibitor; Gastroenterology; Surgery; Clinical trial; Bone marrow; Janus kinase; Myelodysplastic syndromes","authors":[{"name":"Francesco Passamonti","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Bruno Martino","is_ca":false},{"name":"Lynda Foltz","is_ca":true},{"name":"Andrey Zaritskey","is_ca":false},{"name":"Haifa Kathrin Al‐Ali","is_ca":false},{"name":"Renato Tavares Daher","is_ca":false},{"name":"Margherita Maffioli","is_ca":false},{"name":"Pia Raanani","is_ca":false},{"name":"Pilar Giraldo","is_ca":false},{"name":"Martin Grießhammer","is_ca":false},{"name":"Paola Guglielmelli","is_ca":false},{"name":"Catherine Bouard","is_ca":false},{"name":"Carole Paley","is_ca":false},{"name":"Ranjan Tiwari","is_ca":false},{"name":"Alessandro M. Vannucchi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02074939354465334,"gpt":0.3252005367022574,"spread":0.3044511431576041,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003333071,0.0002563491,0.001094641,0.0001793632,0.00006420617,0.00003564326,0.0001402191,0.0001261934,0.00002551449],"category_scores_gemma":[0.0005372397,0.0001525357,0.00004579289,0.0002523076,0.0002506773,0.00009395486,0.0003491083,0.0003664008,0.000002002063],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002900522,"about_ca_system_score_gemma":0.0001096842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007621128,"about_ca_topic_score_gemma":0.0006983683,"domain_scores_codex":[0.9976913,0.0003983811,0.0008050645,0.0005417803,0.0002585332,0.0003049927],"domain_scores_gemma":[0.9978818,0.001330066,0.0003062559,0.0002026297,0.0001518396,0.0001273943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003259434,0.006420154,0.9823825,0.0002042282,0.0001914593,0.0006562304,0.001097712,0.00001409887,0.00001068837,0.0003277666,0.000001895579,0.005433885],"study_design_scores_gemma":[0.02815047,0.003183544,0.9644592,0.0009275122,0.0001562379,0.0001165923,0.001678079,0.00102988,0.0001401121,0.0000211372,0.000005947181,0.0001313149],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976351,0.0001603395,0.00004616459,0.0002344565,0.0001740893,0.001561266,0.00002087112,0.00002553055,0.0001422213],"genre_scores_gemma":[0.9992641,0.0001515918,0.0001510159,0.00005278561,0.000021991,0.0002742082,0.00006582587,0.00001489468,0.000003597449],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02489103,"threshold_uncertainty_score":0.6220227,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3006286575","doi":"10.1002/hon.2723","title":"Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma","year":2020,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Carfilzomib; Ibrutinib; Medicine; Dexamethasone; Refractory (planetary science); Multiple myeloma; Oncology; Internal medicine; Lenalidomide; Leukemia; Materials science","authors":[{"name":"Ajai Chari","is_ca":false},{"name":"Robert F. Cornell","is_ca":false},{"name":"Cristina Gasparetto","is_ca":false},{"name":"Chatchada Karanes","is_ca":false},{"name":"Jeffrey Matous","is_ca":false},{"name":"Rubén Niesvizky","is_ca":false},{"name":"Matthew A. Lunning","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false},{"name":"Larry D. Anderson","is_ca":false},{"name":"Saurabh Chhabra","is_ca":false},{"name":"Saulius Girnius","is_ca":false},{"name":"Chaim Shustik","is_ca":true},{"name":"Robert K. Stuart","is_ca":false},{"name":"Yihua Lee","is_ca":false},{"name":"Zeena Salman","is_ca":false},{"name":"Emily Liu","is_ca":false},{"name":"Jason Valent","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06631480899877269,"gpt":0.3511896877632336,"spread":0.2848748787644609,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001906158,0.0002651221,0.002029407,0.0003716269,0.00003672243,0.000003529973,0.0001630796,0.0001933758,0.0002815618],"category_scores_gemma":[0.0007222465,0.0001579405,0.0001313617,0.001598396,0.000298351,0.00005345845,0.00009804327,0.0003886598,0.000006821278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001109898,"about_ca_system_score_gemma":0.0002042172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000154446,"about_ca_topic_score_gemma":0.0003879615,"domain_scores_codex":[0.9973365,0.0003933605,0.0007299866,0.0005379478,0.0005896975,0.0004124838],"domain_scores_gemma":[0.9977365,0.000862162,0.0003943561,0.00035738,0.0002905045,0.0003590859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06776069,0.03093045,0.8942095,0.00009660218,0.00225868,0.001176761,0.0009757481,0.00004037723,0.00023941,0.00002190046,0.00002636183,0.002263498],"study_design_scores_gemma":[0.09147003,0.09597009,0.8086023,0.00003936353,0.001133054,0.000008841667,0.0007990496,0.001396582,0.0003987292,0.000002462471,0.00004894002,0.0001305125],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976181,0.00004309259,0.00005774191,0.0002513623,0.00001133537,0.001653404,0.00004792069,0.00003282415,0.000284221],"genre_scores_gemma":[0.9977885,0.000005676574,0.001799947,0.0001126986,0.000007412089,0.0001115919,0.0001437667,0.00001740035,0.00001301483],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08560719,"threshold_uncertainty_score":0.6440625,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3111005279","doi":"10.1002/hon.2830","title":"Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland","year":2020,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"WiLAN (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Confidence interval; Population; Retrospective cohort study; Lymphoma; Surgery","authors":[{"name":"Alden A. Moccia","is_ca":false},{"name":"Stefanie Aeppli","is_ca":false},{"name":"Sabine Güsewell","is_ca":false},{"name":"Mario Bargetzi","is_ca":false},{"name":"Clemens B. Caspar","is_ca":false},{"name":"D. Brülisauer","is_ca":false},{"name":"Monika Ebnöther","is_ca":false},{"name":"Martin Fehr","is_ca":false},{"name":"Natalie Fischer","is_ca":false},{"name":"Guido Ghilardi","is_ca":false},{"name":"Fatime Krasniqi","is_ca":false},{"name":"Noémie Lang","is_ca":false},{"name":"Ulrich Mey","is_ca":false},{"name":"Walter Mingrone","is_ca":false},{"name":"Urban Novak","is_ca":false},{"name":"Claudia Pfleger","is_ca":false},{"name":"P Richter","is_ca":false},{"name":"Markus F. Rütti","is_ca":true},{"name":"Adrian Schmidt","is_ca":false},{"name":"Frank Stenner","is_ca":false},{"name":"Michèle Voegeli","is_ca":false},{"name":"Thilo Zander","is_ca":false},{"name":"Emanuele Zucca","is_ca":false},{"name":"Felicitas Hitz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05213350040243925,"gpt":0.3476552728913584,"spread":0.2955217724889191,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009363359,0.0001382124,0.0009932371,0.00003806145,0.00001147976,0.000003719312,0.0000446214,0.0002353658,0.00009603477],"category_scores_gemma":[0.0002380369,0.00008492904,0.00006708672,0.0001230557,0.0001735831,0.0000198577,0.0000547099,0.00008629489,0.00001622586],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006610753,"about_ca_system_score_gemma":0.0000479319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002668218,"about_ca_topic_score_gemma":0.00001447177,"domain_scores_codex":[0.9986936,0.00009804901,0.0006046363,0.0002939119,0.0001247559,0.0001849923],"domain_scores_gemma":[0.9991307,0.0003298407,0.0001831896,0.0001124397,0.00004130164,0.0002025748],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001470131,0.002066034,0.9789441,0.00004927066,0.00006113594,0.002415306,0.00007474659,6.558109e-8,0.000005572838,0.0001697651,0.0001126556,0.01463125],"study_design_scores_gemma":[0.01197969,0.004965074,0.9805939,0.00003303274,0.0001041413,0.00005688683,0.00001794165,0.00004352173,0.00003280012,0.00001219112,0.002075646,0.00008518145],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998302,0.00006804848,0.000003114635,0.0007574711,0.00003302861,0.0003383981,0.00001735495,0.00002235663,0.0004582446],"genre_scores_gemma":[0.9978771,0.00009034729,0.0004782256,0.001451453,0.0000236711,0.00002428761,0.00003578519,0.000009169582,0.000009923634],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01454606,"threshold_uncertainty_score":0.3463306,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4380078158","doi":"10.1002/hon.3163_156","title":"MURANO: Final 7 year follow up and retreatment analysis in venetoclax‐rituximab (VenR)‐treated patients with relapsed/refractory chronic lymphocytic leukemia (<i>R</i>/<i>R</i> CLL)","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; University of Calgary","funders":"F. Hoffmann-La Roche; AstraZeneca","keywords":"Medicine; Bendamustine; Internal medicine; Hazard ratio; Rituximab; Regimen; Confidence interval; Gastroenterology; Chronic lymphocytic leukemia; Refractory (planetary science); Progression-free survival; Surgery; Leukemia; Overall survival; Lymphoma","authors":[{"name":"Arnon P. Kater","is_ca":false},{"name":"Rosemary Harrup","is_ca":false},{"name":"Thomas J. Kipps","is_ca":false},{"name":"Barbara Eichhorst","is_ca":false},{"name":"Carolyn Owen","is_ca":true},{"name":"Sarit Assouline","is_ca":true},{"name":"Nicole Lamanna","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"Javier de la Serna","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Guillaume Cartron","is_ca":false},{"name":"Marco Montillo","is_ca":false},{"name":"Clemens Mellink","is_ca":false},{"name":"Brenda Chyla","is_ca":false},{"name":"Maria Thadani‐Mulero","is_ca":false},{"name":"Marcus Lefebure","is_ca":false},{"name":"Yanwen Jiang","is_ca":false},{"name":"Rosemary Millen","is_ca":false},{"name":"Michelle Boyer","is_ca":false},{"name":"John F. Seymour","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02797735490506649,"gpt":0.3028320781248924,"spread":0.2748547232198259,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004526238,0.0004667474,0.001751673,0.0007521007,0.0001349923,0.0000279137,0.0002335089,0.0006830413,0.000383272],"category_scores_gemma":[0.0003486405,0.0003325044,0.0002516015,0.0026871,0.0005240365,0.0001025447,0.0002542187,0.0005848267,0.0004933639],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.1003905,"about_ca_system_score_gemma":0.01461734,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009241913,"about_ca_topic_score_gemma":0.0007140556,"domain_scores_codex":[0.9959812,0.0003214742,0.0007534437,0.001060484,0.0007302299,0.001153216],"domain_scores_gemma":[0.9976374,0.0008436876,0.0002127652,0.0006912072,0.000167503,0.0004474323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.02877677,0.002490191,0.8966483,0.001517633,0.005464876,0.03437762,0.001607435,0.003615802,0.0006592679,0.001296152,0.008556133,0.01498983],"study_design_scores_gemma":[0.4369117,0.02624332,0.4241382,0.0007823086,0.004118952,0.00161803,0.0005617465,0.08526765,0.001100648,0.0004828328,0.01708753,0.001687018],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956515,0.0006436972,0.00001455964,0.0001744403,0.0001077386,0.001155481,0.00002234625,0.0002623725,0.00196782],"genre_scores_gemma":[0.996944,0.0005920614,0.000290219,0.0002195983,0.00005709442,0.0002640869,0.0003401494,0.00005311687,0.001239696],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4725101,"threshold_uncertainty_score":0.9999127,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2527713631","doi":"10.1002/hon.2351","title":"Proteasome inhibitors in AL amyloidosis: focus on mechanism of action and clinical activity","year":2016,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Ministry of Health, British Columbia; Mental Health Association of Westchester County","keywords":"Ixazomib; Bortezomib; Carfilzomib; Amyloidosis; Multiple myeloma; Proteasome inhibitor; Medicine; Proteasome; AL amyloidosis; Pharmacology; Oncology; Cancer research; Internal medicine; Immunoglobulin light chain; Immunology; Chemistry; Biochemistry","authors":[{"name":"Tomáš Jelı́nek","is_ca":false},{"name":"Elena Kryukova","is_ca":false},{"name":"Fedor Kryukov","is_ca":false},{"name":"Roman Hájek","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07908604674415905,"gpt":0.4205617516177201,"spread":0.341475704873561,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006642241,0.0006196283,0.002953571,0.0001937425,0.00005076571,0.000009686297,0.0002994815,0.002272492,0.0000447732],"category_scores_gemma":[0.0007923127,0.0003978565,0.0007090436,0.0001579994,0.0003781182,0.000007540312,0.0003813611,0.000577803,0.00005166893],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001967883,"about_ca_system_score_gemma":0.0003271214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001571601,"about_ca_topic_score_gemma":0.00005779542,"domain_scores_codex":[0.9956906,0.001280985,0.001195132,0.001145404,0.0001977225,0.0004901873],"domain_scores_gemma":[0.9973846,0.0007954403,0.001027999,0.0005461443,0.00005072424,0.0001950789],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002510151,0.001732217,0.001400006,0.001078398,0.0003677372,0.00009297564,0.00000473766,4.147249e-8,0.0002908944,0.001740875,0.0006310766,0.99241],"study_design_scores_gemma":[0.002953149,0.007579444,0.0007279714,0.004360604,0.0006088716,0.0003780801,0.00002233811,0.000001216907,0.006975684,0.001083649,0.9743664,0.000942615],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03994451,0.9543288,0.00009483715,0.001075581,0.0006370564,0.002970425,0.00008996476,0.00005187245,0.0008069315],"genre_scores_gemma":[0.06175319,0.9367245,0.0002204077,0.0001806747,0.0001636345,0.0008231428,0.00002895347,0.00004944569,0.00005599808],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9914674,"threshold_uncertainty_score":0.9998474,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3176099878","doi":"10.1002/hon.49_2879","title":"IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE PROSPECTIVE IELSG 37 TRIAL","year":2021,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; St. Thomas Hospital; University Health Network","funders":"Pharmacyclics; Swiss Cancer Research Foundation; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Celltrion; BeiGene; AstraZeneca; Celltrion Healthcare; Gilead Sciences; Celgene; Amgen; Pfizer; Cancer Research UK; Incyte; National Science Foundation","keywords":"Medicine; Clinical endpoint; Regimen; Rituximab; Chemoimmunotherapy; Internal medicine; Oncology; Population; Randomized controlled trial; Lymphoma; Surgery","authors":[{"name":"Maurizio Martelli","is_ca":false},{"name":"Emanuele Zucca","is_ca":false},{"name":"Barbara Botto","is_ca":false},{"name":"Irina Kryachok","is_ca":false},{"name":"Luca Ceriani","is_ca":false},{"name":"Monica Balzarotti","is_ca":false},{"name":"Alessandra Tucci","is_ca":false},{"name":"M. G. Cabras","is_ca":false},{"name":"Vittorio Ruggero Zilioli","is_ca":false},{"name":"C. Rusconi","is_ca":false},{"name":"F. Angrilli","is_ca":false},{"name":"Luca Arcaini","is_ca":false},{"name":"A. Dabrowska Iwanicka","is_ca":false},{"name":"Andrés J.M. Ferreri","is_ca":false},{"name":"Francesco Merli","is_ca":false},{"name":"Weili Zhao","is_ca":false},{"name":"David Hodgson","is_ca":true},{"name":"C Ionescu","is_ca":false},{"name":"Alexander Fosså","is_ca":false},{"name":"Kate Cwynarski","is_ca":false},{"name":"G. Mikhaeel","is_ca":true},{"name":"Mats Jerkeman","is_ca":false},{"name":"Andrea Janíková","is_ca":false},{"name":"Andreas Hüttmann","is_ca":false},{"name":"Giovannino Ciccone","is_ca":false},{"name":"Ur Metser","is_ca":true},{"name":"Sally F. Barrington","is_ca":false},{"name":"Bogdan Małkowski","is_ca":false},{"name":"Annibale Versari","is_ca":false},{"name":"F. Espósito","is_ca":false},{"name":"Kelly Cozens","is_ca":false},{"name":"Nicoletta Ielmini","is_ca":false},{"name":"R. Ricardi","is_ca":false},{"name":"Franco Cavalli","is_ca":false},{"name":"Peter Johnson","is_ca":false},{"name":"Alex Davies","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07152412977678226,"gpt":0.3516985184666783,"spread":0.2801743886898961,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003266564,0.0001704479,0.0008680725,0.00004505087,0.00003732047,0.000003941147,0.0001082028,0.0002063902,0.0001715878],"category_scores_gemma":[0.0005004487,0.00006698639,0.000302865,0.0002148129,0.000204816,0.00001550866,0.00005760532,0.000169132,0.000008410047],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006034682,"about_ca_system_score_gemma":0.0003177079,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003740189,"about_ca_topic_score_gemma":0.00001841984,"domain_scores_codex":[0.9982186,0.0004577261,0.0005393252,0.0002568669,0.0002932714,0.0002341997],"domain_scores_gemma":[0.9973764,0.001876881,0.0002790722,0.0003172464,0.00009185362,0.00005851047],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02582048,0.03984598,0.9068415,0.0001193122,0.0003043846,0.001575368,0.001306048,0.000003272641,0.002322933,0.01606408,0.00130743,0.004489173],"study_design_scores_gemma":[0.03625596,0.009825988,0.9413498,0.00004908746,0.0001513646,0.000535506,0.0004513411,0.000004787952,0.01031639,0.0009139306,0.00007730418,0.0000685124],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867396,0.0001790285,0.000002418684,0.003112107,0.0001557965,0.0009293861,0.000006642263,0.000009836538,0.008865177],"genre_scores_gemma":[0.999128,0.00006902422,0.00007285717,0.0003812185,0.00007308483,0.0002111862,0.00001397502,0.000006124883,0.00004450374],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03450828,"threshold_uncertainty_score":0.2731625,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2621758445","doi":"10.1002/hon.2437_99","title":"INTEGRATED ANALYSIS: OUTCOMES OF IBRUTINIB‐TREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA (CLL/SLL) WITH HIGH‐RISK PROGNOSTIC FACTORS","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Ibrutinib; Internal medicine; Chronic lymphocytic leukemia; IGHV@; Ofatumumab; Oncology; Chlorambucil; Leukemia; Univariate analysis; Bendamustine; Multivariate analysis; Chemotherapy; Cyclophosphamide","authors":[{"name":"Thomas J. Kipps","is_ca":false},{"name":"Graeme Fraser","is_ca":true},{"name":"Steven Coutré","is_ca":false},{"name":"Jennifer R. Brown","is_ca":false},{"name":"Jacqueline C. Barrientos","is_ca":false},{"name":"Paul M. Barr","is_ca":false},{"name":"John C. Byrd","is_ca":false},{"name":"Susan O’Brien","is_ca":false},{"name":"M.S. Dilhuydy","is_ca":false},{"name":"Peter Hillmen","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Carol Moreno","is_ca":false},{"name":"Paula Cramer","is_ca":false},{"name":"Stephan Stilgenbauer","is_ca":false},{"name":"A.A. Chanan‐Khan","is_ca":false},{"name":"Michelle Mahler","is_ca":false},{"name":"Mariya Salman","is_ca":false},{"name":"Minghua Cheng","is_ca":false},{"name":"Anil Londhe","is_ca":false},{"name":"Joi Ninomoto","is_ca":false},{"name":"Angela Howes","is_ca":false},{"name":"Danelle F. James","is_ca":false},{"name":"Michael Hallek","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02770539388624377,"gpt":0.2986521199294849,"spread":0.2709467260432412,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005654125,0.001062726,0.004070939,0.0007109077,0.0005719118,0.0001096636,0.001199797,0.001081818,0.0005110747],"category_scores_gemma":[0.002915998,0.000592914,0.0005502039,0.001252683,0.00244526,0.0002237924,0.0004983172,0.0008918252,0.0001237099],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.1752405,"about_ca_system_score_gemma":0.07060017,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01857213,"about_ca_topic_score_gemma":0.003710008,"domain_scores_codex":[0.993475,0.0005000854,0.00151417,0.001555182,0.001260517,0.001695104],"domain_scores_gemma":[0.991825,0.002061136,0.001776944,0.002428361,0.001064188,0.000844368],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004462988,0.000440789,0.9837152,0.0004457118,0.005498058,0.001775999,0.0001772004,0.001786875,0.00006369422,0.000397462,0.0001118024,0.001124227],"study_design_scores_gemma":[0.07454024,0.01207438,0.8761219,0.0004973137,0.007846694,0.0004607532,0.0002151527,0.02381745,0.003131386,0.00008544291,0.0002881976,0.0009211054],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951672,0.0002089757,0.0002973712,0.00007912133,0.0001349206,0.002297068,0.00009932758,0.0003516162,0.001364376],"genre_scores_gemma":[0.9967101,0.0001380837,0.001612165,0.0001181276,0.00005407908,0.0002527774,0.0004593323,0.0001101752,0.0005451717],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1075933,"threshold_uncertainty_score":0.9996522,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2891861976","doi":"10.1002/hon.2560","title":"Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin","year":2018,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Refractory (planetary science); Anaplastic large-cell lymphoma; Internal medicine; Salvage therapy; Surgery; Gastroenterology; Lymphoma; Chemotherapy; Oncology; CD30","authors":[{"name":"Dai Chihara","is_ca":false},{"name":"Shannon Wong","is_ca":true},{"name":"Tatyana Feldman","is_ca":false},{"name":"Michelle A. Fanale","is_ca":false},{"name":"Larysa Sanchez","is_ca":false},{"name":"Joseph M. Connors","is_ca":true},{"name":"Kerry J. Savage","is_ca":true},{"name":"Yasuhiro Oki","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02367617166302798,"gpt":0.3013416210523374,"spread":0.2776654493893094,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001376844,0.0002951705,0.001252915,0.0001096259,0.00009494453,0.000006740683,0.0001335221,0.0003747059,0.001154738],"category_scores_gemma":[0.0003230452,0.000158012,0.0001379427,0.0001799449,0.0003537213,0.00005210978,0.0001074959,0.0001150721,0.0002325001],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003532847,"about_ca_system_score_gemma":0.000227231,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001894136,"about_ca_topic_score_gemma":0.0001208746,"domain_scores_codex":[0.9978548,0.0001424358,0.0006778017,0.000485847,0.0003291946,0.0005099371],"domain_scores_gemma":[0.9980593,0.0006477459,0.0003644901,0.0003999581,0.0002751501,0.00025333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006168655,0.01715753,0.970431,0.0001260623,0.0001270724,0.0007219661,0.0001598042,1.120415e-7,0.0000151109,0.0004596996,0.00262171,0.002011225],"study_design_scores_gemma":[0.04591525,0.0254436,0.902164,0.000102228,0.0003119927,0.0000918808,0.0001338688,0.00006498853,0.001583594,0.00003503063,0.02393245,0.0002210816],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990899,0.00009516723,0.00007286422,0.0002839714,0.0001673485,0.000636988,0.0000416079,0.00006551404,0.00773752],"genre_scores_gemma":[0.9970659,0.00002126212,0.00129798,0.0007906722,0.00005937388,0.00008270919,0.0000655703,0.00002481695,0.0005917052],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06826703,"threshold_uncertainty_score":0.9997584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4379981441","doi":"10.1002/hon.3164_163","title":"Characterization of Mechanisms of Resistance in Previously Treated Chronic Lymphocytic Leukemia (CLL) From a Head‐to‐Head Trial of Acalabrutinib Versus Ibrutinib","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Ibrutinib; Bruton's tyrosine kinase; Chronic lymphocytic leukemia; Medicine; Oncology; Progression-free survival; Fludarabine; Cancer research; Internal medicine; Immunology; Leukemia; Tyrosine kinase; Chemotherapy; Receptor","authors":[{"name":"Jennifer A. Woyach","is_ca":false},{"name":"Dan Jones","is_ca":false},{"name":"Wojciech Jurczak","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"Árpád Illés","is_ca":false},{"name":"Arnon P. Kater","is_ca":false},{"name":"Paolo Ghia","is_ca":false},{"name":"John C. Byrd","is_ca":false},{"name":"John F. Seymour","is_ca":false},{"name":"Susan K. De Long","is_ca":false},{"name":"Nihal Mohamed","is_ca":false},{"name":"G. De Jesus","is_ca":false},{"name":"Rai‐Hua Lai","is_ca":false},{"name":"Gerjan de Bruin","is_ca":false},{"name":"A Butturini","is_ca":false},{"name":"Simon Rule","is_ca":true},{"name":"Veerendra Munugalavadla","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07190435046110251,"gpt":0.3793572972091509,"spread":0.3074529467480484,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008933184,0.0002926256,0.002116313,0.0004632087,0.00003029052,0.00000436032,0.0003632855,0.0005926255,0.0002461031],"category_scores_gemma":[0.002073593,0.0002439637,0.0002263307,0.001867065,0.0004720844,0.00005323083,0.0002487508,0.0003064591,0.00009708157],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02572832,"about_ca_system_score_gemma":0.01644402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001464921,"about_ca_topic_score_gemma":0.001461261,"domain_scores_codex":[0.9958551,0.0004588327,0.001635102,0.0006524313,0.0006632566,0.0007352763],"domain_scores_gemma":[0.9962825,0.001917038,0.0006500326,0.0006678349,0.0002353978,0.000247173],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4054013,0.001112334,0.000511066,0.001911802,0.0003776028,0.001327388,0.001267254,0.0001245727,0.5738627,0.008587789,0.000322228,0.00519397],"study_design_scores_gemma":[0.5993744,0.02828207,0.008945332,0.001969095,0.0003465672,0.00008899782,0.0003203852,0.009544925,0.3470002,0.001891481,0.001709234,0.0005273314],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956609,0.000126912,0.0001620867,0.0003218639,0.0002551753,0.002150991,0.00006239347,0.0001071732,0.001152489],"genre_scores_gemma":[0.9979243,0.0002697391,0.0008744081,0.00006243572,0.00008508173,0.0002201386,0.0002330812,0.00003592434,0.000294844],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2268626,"threshold_uncertainty_score":0.994855,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4310179086","doi":"10.1002/hon.3102","title":"The role of Vertebral Augmentation Procedures in the management of vertebral compression fractures secondary to multiple myeloma","year":2022,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Kyphosis; Vertebral body; Bone cement; Vertebral compression fracture; Percutaneous vertebroplasty; Balloon; Surgery; Percutaneous; Radiology; Radiography; Cement","authors":[{"name":"Kelechi Eseonu","is_ca":true},{"name":"Jaykar R. Panchmatia","is_ca":true},{"name":"Matthew Streetly","is_ca":true},{"name":"Jonathan N. Grauer","is_ca":false},{"name":"Bahram Fakouri","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05215859064356804,"gpt":0.3958581806660868,"spread":0.3436995900225188,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004492802,0.0003177892,0.001828218,0.0001699144,0.0001054364,0.000006263178,0.0006094595,0.0003543108,0.001017374],"category_scores_gemma":[0.0002199521,0.0001398657,0.0004554276,0.0003268492,0.0002202537,0.00003636133,0.0004118606,0.0006009534,0.0000279504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001424255,"about_ca_system_score_gemma":0.0002113805,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001479976,"about_ca_topic_score_gemma":0.00004513246,"domain_scores_codex":[0.9970669,0.0006870309,0.001129314,0.0004164596,0.0003397831,0.0003605579],"domain_scores_gemma":[0.9984891,0.0004403084,0.0005241206,0.0004397497,0.00003676803,0.00006999595],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002191956,0.000700662,0.000263024,0.00644451,0.0002543293,0.0003195622,0.0002860947,9.155236e-7,0.00004773639,0.004277728,0.004137942,0.9830483],"study_design_scores_gemma":[0.001505194,0.002484285,0.008227496,0.003574376,0.0005163057,0.0007310529,0.001575878,0.00001968982,0.0001221078,0.0007203303,0.9803241,0.0001991787],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006296005,0.9812632,0.00002444004,0.0007290343,0.0002774578,0.002683363,0.00004621874,0.00002794376,0.008652306],"genre_scores_gemma":[0.06469221,0.9318658,0.0006078354,0.001112246,0.00005946226,0.001355866,0.0001557985,0.00003215356,0.0001186311],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9828491,"threshold_uncertainty_score":0.9998958,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2623202484","doi":"10.1002/hon.2437_130","title":"FIRST‐LINE TREATMENT OF INHL OR MCL PATIENTS WITH BR OR R‐CHOP/R‐CVP: RESULTS OF THE BRIGHT 5‐YEAR FOLLOW‐UP STUDY","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Rituximab; Vincristine; Prednisone; CHOP; Internal medicine; Hazard ratio; Gastroenterology; Mantle cell lymphoma; Cyclophosphamide; Confidence interval; Lymphoma; Surgery; Oncology; Chemotherapy","authors":[{"name":"Ian W. Flinn","is_ca":false},{"name":"Richard van der Jagt","is_ca":true},{"name":"Julie Chang","is_ca":false},{"name":"Peter Wood","is_ca":false},{"name":"T Hawkins","is_ca":false},{"name":"David MacDonald","is_ca":true},{"name":"Judith Trotman","is_ca":false},{"name":"David Simpson","is_ca":false},{"name":"Kathryn S. Kolibaba","is_ca":false},{"name":"Samar Issa","is_ca":false},{"name":"Doreen M. Hallman","is_ca":false},{"name":"L. Chen","is_ca":false},{"name":"John M. Burke","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06503796508252431,"gpt":0.3461452574412059,"spread":0.2811072923586816,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001214918,0.0002647873,0.001237947,0.00004474994,0.0002208007,0.000009756603,0.0002548563,0.0002064974,0.0002416795],"category_scores_gemma":[0.0006141891,0.00009474866,0.0001834662,0.0001065117,0.0003753041,0.0000405464,0.0001429684,0.00007524456,0.00002288302],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002514861,"about_ca_system_score_gemma":0.0002656213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003403607,"about_ca_topic_score_gemma":0.001800045,"domain_scores_codex":[0.9981652,0.0001287605,0.0006573194,0.000421217,0.0003332952,0.0002942191],"domain_scores_gemma":[0.9974103,0.0005818656,0.0006605726,0.001009072,0.0001992704,0.0001388986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02124885,0.0261747,0.9449356,0.00005242431,0.0005610997,0.0005750452,0.0006292159,0.000001422826,0.000006426736,0.0002173206,0.0009005187,0.004697348],"study_design_scores_gemma":[0.06201797,0.04256954,0.8833182,0.0001324984,0.0006116339,0.00009603779,0.0001709879,0.000006277965,0.001497757,0.00004457236,0.00941578,0.000118764],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993271,0.00006113986,0.000001603453,0.00212217,0.0002221046,0.001885238,0.00006698659,0.00002250081,0.002347237],"genre_scores_gemma":[0.9978696,0.0001077729,0.000363859,0.0001091787,0.00004044113,0.0001810679,0.00001477537,0.00001452165,0.001298854],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06161745,"threshold_uncertainty_score":0.3863738,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4319826530","doi":"10.1002/hon.3126","title":"Predictors of ibrutinib‐associated atrial fibrillation: 5‐year follow‐up of a prospective study","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministero della Salute","keywords":"Ibrutinib; Atrial fibrillation; Medicine; Internal medicine; Cardiology; Prospective cohort study; Cohort; Incidence (geometry); Chronic lymphocytic leukemia; Leukemia","authors":[{"name":"Veronica Mattiello","is_ca":false},{"name":"Angelica Barone","is_ca":false},{"name":"Diana Giannarelli","is_ca":false},{"name":"Alessandro Noto","is_ca":false},{"name":"Nicola Cecchi","is_ca":false},{"name":"Nicolò Rampi","is_ca":false},{"name":"Ramona Cassin","is_ca":false},{"name":"Gianluigi Reda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0553593713309901,"gpt":0.3744604305517121,"spread":0.319101059220722,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008792476,0.0001620008,0.001201665,0.0002008038,0.00004885181,0.000003376886,0.00015552,0.0003908131,0.0003549209],"category_scores_gemma":[0.004515382,0.0001198504,0.0003047627,0.001125775,0.0003670125,0.00003229484,0.0002400762,0.0002417919,0.00009792055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002508127,"about_ca_system_score_gemma":0.003339497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000885524,"about_ca_topic_score_gemma":0.00003541974,"domain_scores_codex":[0.9974273,0.0003241482,0.0007838063,0.0003898217,0.0006488972,0.0004260335],"domain_scores_gemma":[0.9973018,0.0015476,0.0003144727,0.000329021,0.0003559678,0.0001511724],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006139056,0.0007471924,0.9811829,0.0002140027,0.001196746,0.0007711052,0.002446531,0.0000597088,0.0005812994,0.002010681,0.004173844,0.0004768942],"study_design_scores_gemma":[0.2437436,0.05299836,0.6747243,0.0003337772,0.001259472,0.0007410119,0.00811883,0.005580888,0.005725054,0.00302792,0.003154552,0.0005922963],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927842,0.00008700391,0.00000542819,0.0002792414,0.0003670544,0.001641165,0.00001671411,0.0001632231,0.004655977],"genre_scores_gemma":[0.9989151,0.00003793116,0.00009045147,0.00001332902,0.0001955418,0.00002901296,0.00002979215,0.00001812861,0.0006706825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3064587,"threshold_uncertainty_score":0.6558666,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2604118521","doi":"10.1002/hon.2411","title":"Follicular lymphoma: State‐of‐the‐art ICML workshop in Lugano 2015","year":2017,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"Instituto de Ciencias del Mar y Limnología, Universidad Nacional Autónoma de México; European School of Oncology; Cancer Research UK; American Association for Cancer Research","keywords":"Follicular lymphoma; Epigenetics; Clinical Oncology; Lymphoma; Medicine; Oncology; Internal medicine; Cancer; Biology; Genetics; Gene","authors":[{"name":"Randy D. Gascoyne","is_ca":true},{"name":"Bertrand Nadel","is_ca":false},{"name":"Laura Pasqualucci","is_ca":false},{"name":"Jude Fitzgibbon","is_ca":false},{"name":"Jacqueline E. Payton","is_ca":false},{"name":"Ari Melnick","is_ca":false},{"name":"Oliver Weigert","is_ca":false},{"name":"Karin Tarte","is_ca":false},{"name":"John G. Gribben","is_ca":false},{"name":"Jonathan W. Friedberg","is_ca":false},{"name":"John F. Seymour","is_ca":false},{"name":"Franco Cavalli","is_ca":false},{"name":"Emanuele Zucca","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.128309007466073,"gpt":0.4340798591280272,"spread":0.3057708516619542,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004220626,0.000577943,0.005419339,0.0001725617,0.00009533601,0.00001722256,0.0005572404,0.001117359,0.0001911429],"category_scores_gemma":[0.0008605029,0.0002971988,0.001216339,0.0002821311,0.0004410756,0.00003559202,0.0004017411,0.0003550579,0.0005074331],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009623921,"about_ca_system_score_gemma":0.001420316,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002380132,"about_ca_topic_score_gemma":0.00009244691,"domain_scores_codex":[0.9966299,0.000452238,0.001306195,0.0006892657,0.000337944,0.0005844658],"domain_scores_gemma":[0.9963634,0.001063142,0.001032015,0.001230622,0.00008442345,0.0002264025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005924179,0.002883419,0.001931516,0.004558766,0.0003924655,0.004437742,0.0000307073,2.556976e-7,9.916031e-8,0.00080898,0.01542148,0.9694753],"study_design_scores_gemma":[0.002573323,0.0003798886,0.001430163,0.008495941,0.001107274,0.002748715,0.000007616198,0.000001391066,0.000006305912,0.0002235493,0.9827716,0.0002542663],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006434828,0.9883118,0.000002572337,0.001229499,0.0005345535,0.001877063,0.00002248271,0.00003992397,0.007338581],"genre_scores_gemma":[0.001320502,0.995361,0.0002626566,0.0002667826,0.00007757861,0.0006715857,0.00005691739,0.00004015203,0.001942833],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9692211,"threshold_uncertainty_score":0.999948,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2073588844","doi":"10.1002/hon.935","title":"Vav‐1 expression correlates with NFκB activation and CD40‐mediated cell death in diffuse large B‐cell lymphoma cell lines","year":2010,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; McGill University and Génome Québec Innovation Centre; Jewish General Hospital","funders":"","keywords":"Germinal center; Diffuse large B-cell lymphoma; Cancer research; Lymphoma; CD40; B cell; Biology; Gene expression profiling; Cell; Cell culture; Gene expression; Immunology; Antibody; Gene; Cytotoxic T cell; In vitro; Genetics","authors":[{"name":"Annette Hollmann","is_ca":true},{"name":"Raquel Aloyz","is_ca":true},{"name":"Kristi Baker","is_ca":true},{"name":"Stephan Dirnhofer","is_ca":false},{"name":"Trevor Owens","is_ca":false},{"name":"Robert Sladek","is_ca":true},{"name":"Alexandar Tzankov","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01392594052597661,"gpt":0.2678761809839723,"spread":0.2539502404579957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001681158,0.0002821496,0.0006597199,0.0001197682,0.00009085018,0.00001617165,0.00008243069,0.0005313401,0.0001268446],"category_scores_gemma":[0.0001116698,0.0001683461,0.00006111809,0.0001564249,0.0001078683,0.00007728123,0.00009672613,0.0002668441,0.00008579889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001130786,"about_ca_system_score_gemma":0.0001181413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003540636,"about_ca_topic_score_gemma":0.00006182064,"domain_scores_codex":[0.9984133,0.0001275831,0.0003741504,0.0004840787,0.0001730328,0.0004278296],"domain_scores_gemma":[0.998408,0.0008313989,0.0001974982,0.0002492606,0.00006584527,0.000248054],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009099177,0.02885325,0.8932866,0.000152631,0.00001746499,0.002009612,0.0003994504,9.22028e-7,0.07232915,0.0003103001,0.0007039295,0.001026712],"study_design_scores_gemma":[0.06708867,0.0030438,0.5843744,0.0001704347,0.0001524455,0.0007071778,0.0003554117,0.0005301799,0.3345735,0.00021477,0.008368769,0.0004204123],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917353,0.0002682086,0.00004234242,0.0006682891,0.0001317438,0.0005492881,0.000007150186,0.00009509339,0.006502633],"genre_scores_gemma":[0.9964066,0.0002225498,0.002166154,0.0007073677,0.00005876927,0.0001352366,0.00008896925,0.00002402893,0.0001903591],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3089122,"threshold_uncertainty_score":0.6864954,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2996879561","doi":"10.1002/hon.2708","title":"Radiotherapy in mantle cell lymphoma: A literature review","year":2019,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mantle cell lymphoma; Radiation therapy; Lymphoma; Malignancy; Stage (stratigraphy); Disease; Oncology; Internal medicine; Systemic therapy; Cancer","authors":[{"name":"Sharon Ben Barouch","is_ca":true},{"name":"John Kuruvilla","is_ca":true},{"name":"Richard Tsang","is_ca":true},{"name":"Eva Yashphe","is_ca":false},{"name":"Nadav Sarid","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06253466837350785,"gpt":0.3986835428973755,"spread":0.3361488745238677,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002920041,0.0006559047,0.006992634,0.0002225684,0.0000262984,0.00001617727,0.0002405846,0.001430772,0.0006161106],"category_scores_gemma":[0.00009110769,0.0003696356,0.001099766,0.0006212691,0.00008159624,0.0000319126,0.00009157279,0.0004152301,0.0009976615],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001224086,"about_ca_system_score_gemma":0.0008037782,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004035747,"about_ca_topic_score_gemma":0.000002288288,"domain_scores_codex":[0.996826,0.0004759659,0.001110506,0.0008281767,0.0002204868,0.0005388493],"domain_scores_gemma":[0.9978907,0.0007198268,0.0004503863,0.0006797272,0.00005264738,0.0002066718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000034589,0.003344525,0.00009948699,0.1637411,0.000156427,0.01135617,0.00001750873,9.16069e-9,8.593163e-8,0.0006983773,0.01658821,0.8039635],"study_design_scores_gemma":[0.003135048,0.0008369649,0.00003141312,0.1226737,0.001166663,0.00897189,0.000001980997,7.345313e-7,6.815945e-7,0.00002286282,0.8628798,0.0002782748],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001076264,0.9831043,0.000001256118,0.00118201,0.0002744553,0.003107257,0.00002433372,0.0000620688,0.01223358],"genre_scores_gemma":[0.000007202039,0.9930258,0.0007787047,0.003503663,0.0001172447,0.0009616486,0.0003089721,0.00005078196,0.001246008],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8462916,"threshold_uncertainty_score":0.9998755,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2624535566","doi":"10.1002/hon.2437_81","title":"THE 23‐GENE GENE EXPRESSION‐BASED ASSAY DOES NOT PREDICT INTERIM PET SCAN RESULTS AFTER ABVD IN ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA IN THE US INTERGROUP S0816 TRIAL","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Oncology; Clinical endpoint; Lymphoma; Internal medicine; Context (archaeology); Stage (stratigraphy); Interim analysis; Dacarbazine; Surrogate endpoint; Clinical trial; Nuclear medicine; Chemotherapy; Biology; Cyclophosphamide","authors":[{"name":"David W. Scott","is_ca":true},{"name":"H. Li","is_ca":false},{"name":"Yasmin Harvey","is_ca":true},{"name":"Fong Chun Chan","is_ca":true},{"name":"Anja Mottok","is_ca":true},{"name":"M. Boyle","is_ca":true},{"name":"Andrew M. Evens","is_ca":false},{"name":"Heiko Schöder","is_ca":false},{"name":"David J. Straus","is_ca":false},{"name":"Nancy L. Bartlett","is_ca":false},{"name":"John Sweetenham","is_ca":false},{"name":"Paul M. Barr","is_ca":false},{"name":"Michelle A. Fanale","is_ca":false},{"name":"Eric D. Hsi","is_ca":false},{"name":"James R. Cook","is_ca":false},{"name":"Brad S. Kahl","is_ca":false},{"name":"John P. Leonard","is_ca":false},{"name":"Jonathan W. Friedberg","is_ca":false},{"name":"Michael LeBlanc","is_ca":false},{"name":"Christian Steidl","is_ca":true},{"name":"Randy D. Gascoyne","is_ca":true},{"name":"Lisa M. Rimsza","is_ca":false},{"name":"Oliver W. Press","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0370597856809882,"gpt":0.3473945094879564,"spread":0.3103347238069682,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001546838,0.0004116951,0.001097453,0.0001161444,0.0003040719,0.000141113,0.000762777,0.000403246,0.00007331849],"category_scores_gemma":[0.002472809,0.0001714754,0.0002870566,0.0001155128,0.0007047793,0.0001387804,0.0003733875,0.0003779964,0.000039267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006754313,"about_ca_system_score_gemma":0.0003167783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000850274,"about_ca_topic_score_gemma":0.001362489,"domain_scores_codex":[0.995728,0.001148521,0.00110197,0.0008153468,0.0004735372,0.0007325795],"domain_scores_gemma":[0.9951399,0.002772259,0.0005020502,0.001319479,0.00006643927,0.0001998794],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6011412,0.02862645,0.2229427,0.0001467347,0.0003082319,0.05737877,0.001555716,0.00002217739,0.0128877,0.00215165,0.004696857,0.06814175],"study_design_scores_gemma":[0.2154378,0.009510658,0.6866232,0.0005450196,0.0001416947,0.0007784921,0.0004912306,0.0005876212,0.04961932,0.0003704259,0.03538132,0.0005132036],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9799646,0.000208909,0.00003856674,0.01535305,0.0008450518,0.001640924,0.00009306923,0.00005060304,0.001805235],"genre_scores_gemma":[0.9941209,0.000168523,0.001165732,0.001820754,0.0002294286,0.00202881,0.00005824581,0.00002343838,0.0003841616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4636804,"threshold_uncertainty_score":0.6992562,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3174532254","doi":"10.1002/hon.51_2879","title":"NIVOLUMAB PLUS BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: EXTENDED FOLLOW‐UP FROM THE PHASE 2 CHECKMATE 436 STUDY","year":2021,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Nivolumab; Refractory (planetary science); Oncology; Phases of clinical research; Gastroenterology; Lymphoma; Surgery; CD30; Chemotherapy; Cancer; Immunotherapy","authors":[{"name":"Pier Luigi Zinzani","is_ca":false},{"name":"Armando Santoro","is_ca":false},{"name":"Giuseppe Gritti","is_ca":false},{"name":"Pauline Brice","is_ca":false},{"name":"Paul M. Barr","is_ca":false},{"name":"John Kuruvilla","is_ca":true},{"name":"David Cunningham","is_ca":false},{"name":"J. Kline","is_ca":false},{"name":"Nathalie A. Johnson","is_ca":true},{"name":"Neha Mehta–Shah","is_ca":false},{"name":"Michelle A. Fanale","is_ca":false},{"name":"Stephen Francis","is_ca":false},{"name":"Alison J. Moskowitz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04112583095400109,"gpt":0.3361191188900827,"spread":0.2949932879360816,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000497763,0.0004741059,0.00164486,0.00005374688,0.0003460562,0.00003939283,0.0002926574,0.0004511902,0.0007723502],"category_scores_gemma":[0.0007375673,0.0002947748,0.0004980491,0.0002387189,0.0001911763,0.00007500294,0.0003260119,0.0002748936,0.000203206],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001010582,"about_ca_system_score_gemma":0.001369119,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000638749,"about_ca_topic_score_gemma":0.0001486583,"domain_scores_codex":[0.9962912,0.0004962415,0.0008836468,0.001001628,0.0004872413,0.0008400059],"domain_scores_gemma":[0.9955826,0.002680964,0.0003611378,0.0007603451,0.0002627505,0.0003521325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.03414829,0.5118765,0.09550878,0.000669338,0.003791548,0.05634636,0.008169873,0.000002308062,0.006500059,0.004031371,0.1278228,0.1511327],"study_design_scores_gemma":[0.5507624,0.02309084,0.1907958,0.0002185636,0.003656542,0.002728962,0.007962977,0.0004572066,0.00798427,0.001322371,0.2100298,0.0009902662],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845056,0.005179495,0.0002571445,0.003137891,0.001154548,0.002047747,0.0001995651,0.0001731388,0.003344872],"genre_scores_gemma":[0.9918528,0.000253471,0.001711272,0.003128171,0.000347175,0.0011198,0.0006750185,0.00004783703,0.000864486],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5166141,"threshold_uncertainty_score":0.9999504,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4380084938","doi":"10.1002/hon.3163_95","title":"GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (<i>R</i>/<i>R</i>) LARGE B‐CELL LYMPHOMA (LBCL): EXTENDED FOLLOW‐UP AND LANDMARK ANALYSES FROM A PIVOTAL PHASE II STUDY","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"Kite Pharma; F. Hoffmann-La Roche; Genentech; Celgene; Gilead Sciences; Pharmacyclics; Sanofi; Pfizer; Bristol-Myers Squibb","keywords":"Refractory (planetary science); Medicine; Lymphoma; Oncology; Internal medicine; Physics","authors":[{"name":"Michael Dickinson","is_ca":false},{"name":"Carmelo Carlo‐Stella","is_ca":false},{"name":"Franck Morschhauser","is_ca":false},{"name":"Lorenzo Falchi","is_ca":false},{"name":"Emmanuel Bachy","is_ca":false},{"name":"Guillaume Cartron","is_ca":false},{"name":"Cyrus Khan","is_ca":false},{"name":"Monica Tani","is_ca":false},{"name":"Joaquín Martínez‐López","is_ca":false},{"name":"Nancy L. Bartlett","is_ca":false},{"name":"Antonio Salar","is_ca":false},{"name":"Joshua Brody","is_ca":false},{"name":"Sirpa Leppä","is_ca":false},{"name":"E. Mulvihill","is_ca":false},{"name":"Linda Lundberg","is_ca":false},{"name":"James Relf","is_ca":false},{"name":"Youhua Xie","is_ca":true},{"name":"Alessia Bottos","is_ca":false},{"name":"K. Humphrey","is_ca":false},{"name":"Martin Hutchings","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04688872729011315,"gpt":0.3771005735176207,"spread":0.3302118462275075,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005888859,0.0004231723,0.001469336,0.0004204212,0.0001917593,0.00002709053,0.0002298418,0.0004237392,0.001305497],"category_scores_gemma":[0.0001905736,0.0002909395,0.0001551615,0.0009615636,0.0002294796,0.0001087136,0.0002652948,0.0004959323,0.00008759383],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002780245,"about_ca_system_score_gemma":0.0002324223,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001736561,"about_ca_topic_score_gemma":0.0003299672,"domain_scores_codex":[0.9962661,0.0005772116,0.00067179,0.0009484934,0.0006576342,0.0008787843],"domain_scores_gemma":[0.9978475,0.0008779567,0.0001916583,0.0005730202,0.0001400639,0.0003698171],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05571701,0.06990155,0.8113313,0.00007525838,0.0007295393,0.005829053,0.003766075,0.000001544212,0.01106109,0.00004987068,0.002731335,0.03880632],"study_design_scores_gemma":[0.3111354,0.06139693,0.6050625,0.00008202655,0.0002806676,0.00008037707,0.002883125,0.0003562822,0.001197702,0.0003227667,0.01655243,0.0006497646],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954123,0.0004706431,0.00002456953,0.0003555417,0.0001537123,0.001772247,0.00005874844,0.0002122289,0.001539955],"genre_scores_gemma":[0.9967512,0.0001984291,0.0002694669,0.0005696681,0.00006749115,0.0002459032,0.0001848056,0.00005964803,0.001653385],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2554184,"threshold_uncertainty_score":0.9999543,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2142220672","doi":"10.1002/hon.2266","title":"Non‐Hodgkin lymphoma in Romania: a single‐centre experience","year":2015,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Hodgkin lymphoma; Lymphoma; Medicine; Internal medicine","authors":[{"name":"Bogdan Fetică","is_ca":false},{"name":"Patriciu Achimaș-Cădariu","is_ca":false},{"name":"Bogdan Pop","is_ca":false},{"name":"Delia Dima","is_ca":false},{"name":"L. N. Petrov","is_ca":false},{"name":"Anamarija M. Perry","is_ca":true},{"name":"Bharat N. Nathwani","is_ca":false},{"name":"Hans Konrad Müller‐Hermelink","is_ca":false},{"name":"J Diébold","is_ca":false},{"name":"Kenneth MacLennan","is_ca":false},{"name":"Annamaria Fulop","is_ca":false},{"name":"Mihaiela L. Blaga","is_ca":false},{"name":"Daniela Coza","is_ca":false},{"name":"Florian Al. Nicula","is_ca":false},{"name":"Alexandru Irimie","is_ca":false},{"name":"Dennis D. Weisenburger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06943261231885393,"gpt":0.3354643070766122,"spread":0.2660316947577582,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001343706,0.0001989765,0.0007297712,0.00008517747,0.00002912699,0.0000109399,0.0001086898,0.0003128811,0.0002124561],"category_scores_gemma":[0.0002713999,0.0001366124,0.00009659115,0.0002338935,0.0001590308,0.00005236951,0.0001018314,0.00008105567,0.0004024055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008590516,"about_ca_system_score_gemma":0.0002382214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000737645,"about_ca_topic_score_gemma":0.00011499,"domain_scores_codex":[0.99845,0.00008054148,0.0003948759,0.0004154645,0.0002161099,0.0004429463],"domain_scores_gemma":[0.9990346,0.000180753,0.00008903204,0.0002573421,0.00007115807,0.0003670903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009859959,0.01345539,0.9141741,0.00004311652,0.00006560051,0.02355479,0.003765803,0.000002241021,0.000770908,0.008740263,0.009525836,0.024916],"study_design_scores_gemma":[0.04318297,0.01005175,0.6351006,0.0003096215,0.0001926126,0.01030581,0.007086362,0.0004774278,0.01308387,0.002301394,0.2771174,0.0007901562],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9493597,0.0004537044,0.00001376495,0.003880129,0.0001889321,0.0003899709,0.000001319004,0.00007401843,0.0456385],"genre_scores_gemma":[0.9960523,0.0000224216,0.001804856,0.001682468,0.00005507465,0.0001359159,0.00001051581,0.0000110481,0.0002254495],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2790735,"threshold_uncertainty_score":0.5570891,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3092926650","doi":"10.1002/hon.2818","title":"Clinical trial risk in leukemia: Biomarkers and trial design","year":2020,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Celiac Association; University of Toronto","funders":"","keywords":"Medicine; Myeloid leukemia; Clinical trial; Oncology; Chronic lymphocytic leukemia; Biomarker; Internal medicine; Drug; Leukemia; Pharmacology","authors":[{"name":"Alice Li","is_ca":true},{"name":"Jasper P. Dhanraj","is_ca":true},{"name":"Gilberto Lopes","is_ca":false},{"name":"Jayson L. Parker","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3097116344433638,"gpt":0.5104696459623587,"spread":0.2007580115189949,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.004882868,0.0007293712,0.009334393,0.0003548952,0.00007769452,0.00003103157,0.0004762474,0.004167879,0.0003224396],"category_scores_gemma":[0.01553065,0.0004766327,0.001177501,0.0007943183,0.001102291,0.00004039117,0.000602824,0.00357613,0.0004267722],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01668747,"about_ca_system_score_gemma":0.04239848,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008267043,"about_ca_topic_score_gemma":0.00001575352,"domain_scores_codex":[0.9876049,0.005925715,0.003338188,0.001619376,0.0005515755,0.0009603176],"domain_scores_gemma":[0.9813488,0.01608906,0.0009611418,0.0006787503,0.00006538053,0.0008569231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.2939494,0.0006109133,0.00000546686,0.003463595,0.0004783128,0.009912625,0.00001380014,9.882188e-8,2.58338e-8,0.0001510032,0.00463507,0.6867797],"study_design_scores_gemma":[0.4075755,0.01352202,9.254043e-7,0.001323235,0.001085657,0.002492509,0.00001156239,0.0002106548,1.111135e-7,0.0001454866,0.5733775,0.000254876],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006735187,0.9856913,0.0001543003,0.0002951731,0.0009878533,0.01009712,0.00001502571,0.0001282705,0.001957449],"genre_scores_gemma":[0.00009143902,0.9939377,0.003381235,0.0002312714,0.00112614,0.0010057,0.0000487845,0.00007424449,0.0001034869],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6865248,"threshold_uncertainty_score":0.9997686,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1509594523","doi":"10.1002/hon.2165","title":"Use of non‐steroidal anti‐inflammatory drugs and risk of non‐Hodgkin lymphoma: a systematic review and meta‐analysis","year":2014,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Manitoba Health; Winnipeg Regional Health Authority","funders":"ExxonMobil Research and Engineering Company","keywords":"Medicine; Internal medicine; Odds ratio; Follicular lymphoma; Lymphoma; Epidemiology; Confidence interval; Meta-analysis; Oncology; Aspirin; Chronic lymphocytic leukemia; Relative risk; Leukemia","authors":[{"name":"Xibiao Ye","is_ca":true},{"name":"Natalie Casaclang","is_ca":true},{"name":"Salaheddin M. Mahmud","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06019436790171891,"gpt":0.35641511288956,"spread":0.2962207449878411,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001218306,0.0007663636,0.02619241,0.0004051084,0.00005539151,0.00001461027,0.0001877227,0.0008809842,0.0001021106],"category_scores_gemma":[0.0006723389,0.0004027867,0.002766071,0.0005322049,0.000463459,0.00005169186,0.0002527534,0.0002106427,0.00002204334],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001442176,"about_ca_system_score_gemma":0.0002689379,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007312989,"about_ca_topic_score_gemma":0.00001546717,"domain_scores_codex":[0.9942718,0.001448239,0.002764926,0.0007959105,0.0003455314,0.0003736549],"domain_scores_gemma":[0.9918562,0.003663294,0.003062017,0.0009149027,0.0001994728,0.0003041571],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0000173225,0.000742544,0.000858744,0.8519419,0.1380945,0.000260894,0.00003933963,1.175645e-7,2.245729e-7,0.0001262132,0.0001350345,0.007783086],"study_design_scores_gemma":[0.001098567,0.0007985645,0.0004635251,0.04402433,0.9344133,0.001300683,0.00001282685,0.00001867581,0.000004627309,0.000008215974,0.01755128,0.0003053795],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002287363,0.9934491,0.00002787435,0.00009263372,0.00003069844,0.003840973,0.000106062,0.00002436726,0.0001409298],"genre_scores_gemma":[0.003658242,0.9938536,0.001088843,0.0002445047,0.00001477704,0.0009807501,0.00005709421,0.00003387045,0.00006834994],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8079177,"threshold_uncertainty_score":0.9998424,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1948948104","doi":"10.1002/hon.2176","title":"Economic evaluation of arsenic trioxide for treatment of newly diagnosed acute promyelocytic leukaemia in Canada","year":2014,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Université de Montréal","funders":"Lundbeck Canada","keywords":"Medicine; Arsenic trioxide; Adverse effect; Internal medicine; Cost effectiveness; Quality-adjusted life year; Cost-effectiveness analysis","authors":[{"name":"Jean Lachaîne","is_ca":true},{"name":"Karine Mathurin","is_ca":true},{"name":"Stéphane Barakat","is_ca":false},{"name":"Andre C. Schuh","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02308680159429484,"gpt":0.3040223660789609,"spread":0.2809355644846661,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003376573,0.0001325519,0.0005063216,0.00003164414,0.00001651741,0.000001696011,0.0001351761,0.0002071319,0.00002697287],"category_scores_gemma":[0.0002642069,0.0001056027,0.00009228302,0.0000409412,0.00008298051,0.000002132009,0.00002587304,0.00002958091,0.000001160318],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006375777,"about_ca_system_score_gemma":0.00300085,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01491193,"about_ca_topic_score_gemma":0.1642044,"domain_scores_codex":[0.9987662,0.0001819188,0.0004633513,0.0002838916,0.00009789252,0.0002067201],"domain_scores_gemma":[0.9991882,0.0002068612,0.0002526978,0.0002093798,0.00009420353,0.00004861792],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003063139,0.001577281,0.1091313,0.00063286,0.0007445678,0.00006349708,0.0002927086,0.009860635,0.7092374,0.005011696,0.002303213,0.1580817],"study_design_scores_gemma":[0.009302307,0.00422399,0.004662433,0.00002385387,0.0002462066,0.00007532271,0.0001534497,0.006128554,0.9617404,0.001491992,0.01169778,0.0002536783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974862,0.0005650457,0.0003923069,0.00009525766,0.0001086443,0.0005564572,0.00001294465,0.000002748625,0.0007803829],"genre_scores_gemma":[0.9983923,0.0002161598,0.0009276362,0.00004435494,0.00004212245,0.0002694661,0.00006646011,0.000008781579,0.00003274422],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.252503,"threshold_uncertainty_score":0.9916478,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2623329013","doi":"10.1002/hon.2438_50","title":"PHASE 1B STUDY OF PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE <scp>B</scp>‐CELL LYMPHOMA (<scp>RRPMBCL</scp>): UPDATED RESULTS FROM THE <scp>KEYNOTE</scp>‐013 TRIAL","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Tolerability; Neutropenia; Internal medicine; Pembrolizumab; Regimen; Adverse effect; Population; Cohort; Refractory (planetary science); Surgery; Oncology; Gastroenterology; Toxicity; Cancer; Immunotherapy","authors":[{"name":"Pier Luigi Zinzani","is_ca":false},{"name":"Vincent Ribrag","is_ca":false},{"name":"Craig H. Moskowitz","is_ca":false},{"name":"Jean‐Marie Michot","is_ca":false},{"name":"John Kuruvilla","is_ca":true},{"name":"Nancy L. Bartlett","is_ca":false},{"name":"Arun Balakumaran","is_ca":false},{"name":"Arkendu Chatterjee","is_ca":false},{"name":"Sabine Chlosta","is_ca":false},{"name":"Margaret A. Shipp","is_ca":false},{"name":"Philippe Armand","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02672170501286256,"gpt":0.3030244134812918,"spread":0.2763027084684293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001588819,0.0007862838,0.00237493,0.0002516729,0.0005317579,0.00007771721,0.001223153,0.001089246,0.00005738142],"category_scores_gemma":[0.006228133,0.0004874528,0.00035657,0.0004512929,0.001006219,0.0002732244,0.0004897537,0.001094612,0.00006583129],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005647127,"about_ca_system_score_gemma":0.00096005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004564432,"about_ca_topic_score_gemma":0.0003841421,"domain_scores_codex":[0.992979,0.001125697,0.002102816,0.001333814,0.001184975,0.001273721],"domain_scores_gemma":[0.987651,0.007448076,0.002291648,0.001813357,0.0003891416,0.000406801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3039244,0.2751453,0.246195,0.0003177148,0.002523321,0.005195677,0.01827299,0.000005634248,0.003792205,0.0001174807,0.1285859,0.01592445],"study_design_scores_gemma":[0.5609838,0.03447393,0.3450088,0.0001735582,0.0004407406,0.00008236734,0.003688765,0.00003994147,0.000854252,0.00006117423,0.05409345,0.00009917682],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860274,0.0007392065,0.00001999377,0.0002525952,0.001088651,0.003613667,0.0003956427,0.0001349645,0.007727851],"genre_scores_gemma":[0.9963095,0.0001955031,0.0002490193,0.001199007,0.0003738052,0.0002492566,0.0007248599,0.0000797609,0.0006193575],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2570595,"threshold_uncertainty_score":0.9997577,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2949814266","doi":"10.1002/hon.118_2630","title":"CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL‐TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont; McMaster University","funders":"","keywords":"Cytokine release syndrome; Medicine; Internal medicine; Refractory (planetary science); Gastroenterology; Clinical endpoint; Lymphoma; Diffuse large B-cell lymphoma; Phases of clinical research; Cytokine; Peripheral T-cell lymphoma; Clinical trial; Immunotherapy; Immunology; T cell; Immune system; Cancer; Biology","authors":[{"name":"Veronika Bachanová","is_ca":false},{"name":"Jason R. Westin","is_ca":false},{"name":"Constantine S. Tam","is_ca":false},{"name":"Peter Borchmann","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Joseph P. McGuirk","is_ca":false},{"name":"Harald Holte","is_ca":false},{"name":"Edmund K. Waller","is_ca":false},{"name":"Samantha Jaglowski","is_ca":false},{"name":"Michael Bishop","is_ca":false},{"name":"Charalambos Andreadis","is_ca":false},{"name":"S.R. Foley","is_ca":true},{"name":"Isabelle Fleury","is_ca":true},{"name":"Takanori Teshima","is_ca":false},{"name":"Stephan Mielke","is_ca":false},{"name":"Gilles Salles","is_ca":false},{"name":"P. Joy Ho","is_ca":false},{"name":"Koji Izutsu","is_ca":false},{"name":"Richard T. Maziarz","is_ca":false},{"name":"Koen van Besien","is_ca":false},{"name":"Marie José Kersten","is_ca":false},{"name":"Nina Wagner‐Johnston","is_ca":false},{"name":"Koji Kato","is_ca":false},{"name":"Paolo Corradini","is_ca":false},{"name":"Xingmin Han","is_ca":false},{"name":"Sergei Agoulnik","is_ca":false},{"name":"J. Chu","is_ca":false},{"name":"Lamis Eldjerou","is_ca":false},{"name":"Lida Pacaud","is_ca":false},{"name":"Stephen J. Schuster","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03648638014391697,"gpt":0.3376116835436119,"spread":0.301125303399695,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003589329,0.0003107318,0.001426302,0.0003188635,0.00004283723,0.000003738064,0.0001833615,0.0006616547,0.002201002],"category_scores_gemma":[0.0005287587,0.0002235353,0.0001740255,0.0005175185,0.0002544988,0.00007677104,0.0002625464,0.0005756715,0.0001805565],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002025108,"about_ca_system_score_gemma":0.0001208087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005606926,"about_ca_topic_score_gemma":0.00001387025,"domain_scores_codex":[0.9967701,0.0007265485,0.0007566529,0.000683933,0.000433415,0.0006293522],"domain_scores_gemma":[0.9976528,0.001183451,0.0002864896,0.0004197922,0.0001486353,0.0003088079],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004480741,0.01623336,0.9585636,0.000141388,0.00008777887,0.00200012,0.0001280453,0.000002368153,0.01643693,0.0001015501,0.0000900702,0.001734028],"study_design_scores_gemma":[0.03395745,0.01184967,0.9483857,0.00007151147,0.0001009125,0.000594423,0.00006695381,0.0007371784,0.001919213,0.0001809423,0.001902171,0.0002339526],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949792,0.0003199308,0.000009088615,0.0001754322,0.00009799022,0.001093956,0.00002366892,0.00005458965,0.00324617],"genre_scores_gemma":[0.9976971,0.0002615998,0.0001153722,0.0004323085,0.00001083058,0.00004585575,0.00007481941,0.0000297466,0.001332389],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02947671,"threshold_uncertainty_score":0.9987111,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2624425537","doi":"10.1002/hon.2437_13","title":"DURABLE BENEFIT OF RITUXIMAB MAINTENANCE POST‐AUTOGRAFT IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: 12‐YEAR FOLLOW‐UP OF THE EBMT LYMPHOMA WORKING PARTY LYM1 TRIAL","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Rituximab; Medicine; Autologous stem-cell transplantation; Follicular lymphoma; Maintenance therapy; Internal medicine; Surgery; Oncology; Lymphoma; Salvage therapy; Chemotherapy; Progression-free survival","authors":[{"name":"Ruth Pettengell","is_ca":false},{"name":"Rahman Uddin","is_ca":false},{"name":"Ariane Boumendil","is_ca":false},{"name":"Steve Robinson","is_ca":false},{"name":"Genea Smith","is_ca":false},{"name":"T Hawkins","is_ca":false},{"name":"Bernd Metzner","is_ca":false},{"name":"Marı́a Dolores Caballero","is_ca":false},{"name":"Hervé Tilly","is_ca":false},{"name":"Joanna Romejko‐Jarosińska","is_ca":false},{"name":"I. Bence‐Bruckler","is_ca":true},{"name":"Bik To","is_ca":false},{"name":"Carsten Utoft Niemann","is_ca":false},{"name":"Eva Kimby","is_ca":false},{"name":"Peter Dreger","is_ca":false},{"name":"Norbert Schmitz","is_ca":false},{"name":"A. H. Goldstone","is_ca":false},{"name":"Silvia Montoto","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02219643157301769,"gpt":0.2645807255552944,"spread":0.2423842939822767,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003313912,0.0003233651,0.001600722,0.00008862089,0.0002144875,0.00001888723,0.0004425544,0.0004394324,0.00007198312],"category_scores_gemma":[0.0007140149,0.0001720923,0.0003948699,0.0001727717,0.0005428179,0.00008001231,0.0002453276,0.0001076114,0.00001500859],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004102876,"about_ca_system_score_gemma":0.0003567618,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003600243,"about_ca_topic_score_gemma":0.0002684763,"domain_scores_codex":[0.9974214,0.0001539347,0.0008540651,0.0005257438,0.0004828433,0.0005619536],"domain_scores_gemma":[0.9973279,0.0003674777,0.0009417689,0.0009876982,0.0002286324,0.0001465748],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03250066,0.009030201,0.9455956,0.00006953313,0.0002450024,0.0003052664,0.0001343465,0.000002489496,0.00003996469,0.004932561,0.0002152477,0.006929076],"study_design_scores_gemma":[0.2489276,0.00338749,0.743795,0.0004264111,0.0002293179,0.00006748993,0.00007729559,0.00001705059,0.001300946,0.0004121907,0.001200133,0.0001591539],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933285,0.0001762212,0.000004120201,0.001325205,0.0004512068,0.001497627,0.00001772734,0.00002808278,0.003171363],"genre_scores_gemma":[0.9985594,0.00005338245,0.0007021087,0.0002579468,0.00003503107,0.0002027909,0.00001936938,0.00002400885,0.0001459187],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2164269,"threshold_uncertainty_score":0.7017722,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2622354226","doi":"10.1002/hon.2437_76","title":"CANADIAN CANCER TRIALS GROUP (CCTG) LY.17: A RANDOMIZED PHASE II STUDY EVALUATING NOVEL SALVAGE THERAPY PRE‐AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RR‐DLBCL) ‐ OUTCOME OF IBRUTINIB + R‐GDP","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Canadian Cancer Society","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Salvage therapy; Interim analysis; Oncology; Clinical endpoint; Gemcitabine; Febrile neutropenia; Diffuse large B-cell lymphoma; Population; Neutropenia; Ibrutinib; Chemotherapy regimen; Surgery; Chemotherapy; Randomized controlled trial; Lymphoma; Leukemia","authors":[{"name":"John Kuruvilla","is_ca":true},{"name":"M. Crump","is_ca":true},{"name":"Diego Villa","is_ca":true},{"name":"Muhammad Imran Aslam","is_ca":true},{"name":"Anca Prica","is_ca":true},{"name":"David W. Scott","is_ca":true},{"name":"Nanees Abd-Elsamad","is_ca":true},{"name":"Stephen Couban","is_ca":true},{"name":"Stéphane Doucet","is_ca":true},{"name":"Jill Dudebout","is_ca":true},{"name":"Isabelle Fleury","is_ca":true},{"name":"Graeme Fraser","is_ca":true},{"name":"Jean-François Larouche","is_ca":true},{"name":"Mona Shafey","is_ca":true},{"name":"Pamela Skrabek","is_ca":true},{"name":"Tanya Skamene","is_ca":true},{"name":"Chad Winch","is_ca":true},{"name":"L. E. Shepherd","is_ca":true},{"name":"B.E. Chen","is_ca":true},{"name":"Annette E. Hay","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1357148248903003,"gpt":0.442831365213154,"spread":0.3071165403228537,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01248573,0.0007720394,0.006599358,0.0005421489,0.0006217773,0.00005251732,0.001138393,0.001220483,0.0006919055],"category_scores_gemma":[0.002563737,0.0005270367,0.0008379081,0.0002907681,0.0007481996,0.0001351894,0.0003109353,0.00095459,0.00002477378],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01098941,"about_ca_system_score_gemma":0.01165039,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0823807,"about_ca_topic_score_gemma":0.08154007,"domain_scores_codex":[0.9888029,0.003468731,0.003516881,0.001302976,0.001076694,0.001831798],"domain_scores_gemma":[0.9884571,0.006811051,0.001954098,0.001612481,0.0002618112,0.0009034029],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6063501,0.2278208,0.04473223,0.00190861,0.002102804,0.01940774,0.02527988,0.00004072863,0.0336473,0.0008357958,0.001340611,0.03653342],"study_design_scores_gemma":[0.9708825,0.01256649,0.003318924,0.0002276483,0.0006569503,0.0004226367,0.001005439,0.006614074,0.00258892,0.00006059828,0.001101724,0.0005541058],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850906,0.002694746,0.0001003931,0.0008564405,0.0005874669,0.00824033,0.0002766891,0.00009532896,0.00205797],"genre_scores_gemma":[0.9954261,0.0007124362,0.0003952124,0.0005943723,0.0001531166,0.001563515,0.00005109588,0.00008692063,0.001017299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3645324,"threshold_uncertainty_score":0.9997181,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4379981852","doi":"10.1002/hon.3166_ot28","title":"PHASE 3 TRIAL OF SUBCUTANEOUS EPCORITAMAB + R‐CHOP VERSUS R‐CHOP IN PATIENTS (PTS) WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): EPCORE DLBCL‐2","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"National Institutes of Health; National Cancer Institute; Celgene; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Rituximab; Diffuse large B-cell lymphoma; Vincristine; Cytokine release syndrome; Oncology; Prednisone; CHOP; International Prognostic Index; Cyclophosphamide; Phases of clinical research; CD20; Lymphoma; Discontinuation; Gastroenterology; Clinical trial; Chemotherapy; Cancer; Immunotherapy","authors":[{"name":"Laurie H. Sehn","is_ca":true},{"name":"Martine E.D. Chamuleau","is_ca":false},{"name":"Georg Lenz","is_ca":false},{"name":"Michael Roost Clausen","is_ca":false},{"name":"Corinne Haïoun","is_ca":false},{"name":"Koji Izutsu","is_ca":false},{"name":"Andrew Davies","is_ca":false},{"name":"Jun Zhu","is_ca":false},{"name":"Toshihiko Oki","is_ca":false},{"name":"Edith Szafer‐Glusman","is_ca":false},{"name":"R. Conlon","is_ca":false},{"name":"Hung‐Yi Chiou","is_ca":false},{"name":"David Ipe","is_ca":false},{"name":"Baxter A. Elliot","is_ca":false},{"name":"Gilles Salles","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04596949735079359,"gpt":0.360199123689225,"spread":0.3142296263384314,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000682961,0.0004691513,0.001843908,0.0005331193,0.00009910667,0.00001881077,0.00042483,0.000782718,0.001374758],"category_scores_gemma":[0.001210847,0.0003482715,0.000308864,0.001422184,0.0004347367,0.00007857749,0.0002678324,0.0006354871,0.0003831469],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006317787,"about_ca_system_score_gemma":0.0005650081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007857669,"about_ca_topic_score_gemma":0.0001438821,"domain_scores_codex":[0.9952596,0.0005277157,0.001068783,0.0008815328,0.0009383358,0.001323997],"domain_scores_gemma":[0.9952233,0.002878178,0.0003396761,0.0007742813,0.0002735113,0.0005110459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7539799,0.1548729,0.01718689,0.0003221808,0.0002512051,0.02746606,0.0008637865,0.00000424392,0.002359759,0.0006901312,0.003720069,0.03828283],"study_design_scores_gemma":[0.9072056,0.06839499,0.003915359,0.00008765863,0.0001370027,0.0002846544,0.0005784403,0.0003154017,0.0009759687,0.0001109486,0.01759298,0.0004010334],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894937,0.0001093987,0.0000167837,0.0005352157,0.0007027545,0.002576655,0.00006167234,0.0002182886,0.006285553],"genre_scores_gemma":[0.9971738,0.00031798,0.0002728858,0.0002595634,0.0001837864,0.0003226975,0.0001882085,0.0000764133,0.001204688],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1532256,"threshold_uncertainty_score":0.9998969,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107886618","doi":"10.1002/hon.2048","title":"Successful treatment of non‐Hodgkin lymphoma associated immune thrombocytopenia with involved field radiotherapy","year":2013,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Thrombocytopenic purpura; Immune system; Chemotherapy; Radiation therapy; Immunology; Antibody; clone (Java method); Oncology; Internal medicine; Biology","authors":[{"name":"Tanya Berrang","is_ca":true},{"name":"Caroline Holloway","is_ca":true},{"name":"Jason Hart","is_ca":true},{"name":"Adrian Yee","is_ca":true},{"name":"Brian Berry","is_ca":true},{"name":"Rami Kotb","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02274352515073857,"gpt":0.3064587636854287,"spread":0.2837152385346901,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007865325,0.0003025843,0.001666303,0.00007686154,0.00006894839,0.00001434412,0.000117282,0.0004015377,0.001879759],"category_scores_gemma":[0.00006394623,0.000166046,0.0002166281,0.0002128934,0.0001881867,0.00006530402,0.00002942107,0.00005719037,0.0000948575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006996472,"about_ca_system_score_gemma":0.0002538333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001151131,"about_ca_topic_score_gemma":0.0001255189,"domain_scores_codex":[0.9983523,0.00012493,0.0005301636,0.0003771493,0.0002045544,0.0004108848],"domain_scores_gemma":[0.9983323,0.000673633,0.0002855068,0.0003706941,0.0001514983,0.0001864023],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001394184,0.01698526,0.903945,0.00006126908,0.001651388,0.001322041,0.0005140164,0.00000242,0.007767304,0.0008457862,0.00224609,0.0632652],"study_design_scores_gemma":[0.02834738,0.04009485,0.8435951,0.0001317899,0.0004121652,0.0005337881,0.000337535,0.0002185045,0.08061916,0.0001952253,0.005206295,0.0003081457],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881282,0.001188576,0.00005609021,0.004325492,0.00008307535,0.001211464,0.00000437075,0.0000741931,0.004928582],"genre_scores_gemma":[0.9946887,0.0007839747,0.00270591,0.0009505497,0.00003581868,0.0005280031,0.0000389176,0.00002024615,0.000247906],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07285185,"threshold_uncertainty_score":0.9990327,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385144282","doi":"10.1002/hon.3205","title":"Personalised therapy in follicular lymphoma – is the dial turning?","year":2023,"lang":"en","type":"review","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Genentech; Terry Fox Foundation; ViewRay; Cancer Research UK; Incyte; Eisai; BeiGene; National Cancer Research Institute; AstraZeneca; Celgene; Blood Cancer UK; Gilead Sciences","keywords":"Follicular lymphoma; Medicine; Dial; Oncology; Lymphoma; Internal medicine; Engineering","authors":[{"name":"Kim Linton","is_ca":false},{"name":"Lena Specht","is_ca":false},{"name":"Astrid Pavlovsky","is_ca":false},{"name":"Carrie A. Thompson","is_ca":false},{"name":"Eva Kimby","is_ca":false},{"name":"Daphne de Jong","is_ca":false},{"name":"Loretta J. Nastoupil","is_ca":false},{"name":"Anne‐Ségolène Cottereau","is_ca":false},{"name":"Carla Casulo","is_ca":false},{"name":"Clémentine Sarkozy","is_ca":false},{"name":"Jessica Okosun","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1364764441912303,"gpt":0.4095612211108426,"spread":0.2730847769196124,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004347088,0.0005641525,0.003752075,0.0001737794,0.0001026312,0.00002408613,0.000308746,0.00112176,0.000526352],"category_scores_gemma":[0.0002819244,0.0002551893,0.001267173,0.0005777761,0.0002317567,0.00001855224,0.0001380516,0.0003529409,0.0009988692],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007667813,"about_ca_system_score_gemma":0.000794568,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006419675,"about_ca_topic_score_gemma":0.00001713338,"domain_scores_codex":[0.9969336,0.0005721845,0.0008626753,0.0007116417,0.0003339545,0.000585935],"domain_scores_gemma":[0.996648,0.002268492,0.000347917,0.0005131536,0.00004623922,0.0001761858],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001081717,0.001557488,0.0007852225,0.001921961,0.0007362732,0.01019392,0.0002422217,4.107219e-8,1.707068e-7,0.001501353,0.006903268,0.9760499],"study_design_scores_gemma":[0.003629094,0.0009811749,0.0007938535,0.002618395,0.0006740574,0.002909445,0.00005413764,0.000004516595,0.000002653939,0.0001771019,0.9879058,0.0002497923],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003323718,0.989339,4.753009e-7,0.00273116,0.0002999414,0.002124023,0.00002657161,0.0001227333,0.002032411],"genre_scores_gemma":[0.0006259709,0.9943112,0.00006543013,0.002169497,0.0002342485,0.001975948,0.000104079,0.00005683038,0.000456783],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9810025,"threshold_uncertainty_score":0.99999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}